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Magnetic Resonance Spectroscopy Investigation of Conditioned Auditory Percepts 
Timothy I. Michaels, Ph.D. 
University of Connecticut, 2020 
The neurobiology of hallucinations is complex, and despite over a century of research it has yet 
to be fully characterized. The observation that auditory hallucinations occur in healthy 
individuals may provide new avenues for understanding its neurobiology in psychopathology. 
Bayesian approaches to perception suggest that aberrant experiences can be conditioned, with 
stronger effects in those prone to hallucinations. Through a combination of functional magnetic 
resonance imaging and magnetic resonance spectroscopy, the present study investigated whether 
differences in the endorsement of conditioned hallucinations was associated with differences in 
anterior cingulate cortex (ACC) glutamate and GABA levels in a healthy, college-aged sample 
that differed in their propensity to endorse perceptual abnormalities. Hallucinators were more 
likely to endorse false percepts and were more confident in their responses during a Pavlovian 
conditioning task that paired an auditory stimulus with a visual stimulus. Conditioned 
hallucinations were positively correlated with self-report scores of hallucination-proneness in 
daily life. Hallucinators had a higher ratio of glutamate to creatine in the ACC compared to a 
control region, but there were no such differences in GABA/creatine ratios.  Conservatively, 
these results suggest that the predictive coding account of hallucinations in healthy individuals 
overlaps with the underlying neurobiology of psychosis in disease states, and that such an 
approach may be especially useful for understanding psychosis risk across development.  
 
Keywords: Auditory Hallucinations, Predictive Coding, Magnetic Resonance Spectroscopy, 
Perceptual Abnormalities, Functional Magnetic Resonance Imaging. 
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Magnetic Resonance Spectroscopy Investigation of Conditioned Auditory Percepts 
Despite over a century of research, the pathophysiology of psychosis has yet to be fully 
characterized. The neurobiology of psychosis is complex and likely involves genetic, molecular 
and structural abnormalities across diverse brain regions (Lakhan & Vieira, 2009). Clinically, 
psychosis is characterized by a heterogeneity of symptoms including hallucinations, the strong 
conviction of a sensory experience in the absence of a percept, and delusions, holding strong 
beliefs in the absence of supporting evidence (American Psychiatric Association, 2013).  
Psychotic experiences can contribute to the pathology of serious mental illnesses, such as 
schizophrenia (SZ), which affects 1% of the world’s population (World Health Organization, 
2012). The global public health impact of this severe and chronic mental illness is significant; 
schizophrenia is among the top 10 causes of disability in developed countries (Chong et al., 
2016). Given the heterogeneity of clinical presentation and numerous risk factors, SZ likely 
reflects a state of equifinality in which many different potential pathways can lead to similar 
pathology (Uhlhaas et al., 2017). In order to elucidate more specific mechanisms, it is important 
to isolate clinical characteristics that confer increased risk and identify their underlying 
neurobiological mechanisms, thereby linking physiological markers of disease risk with 
symptom phenomenology.  
One promising approach for an improved understanding of psychosis in disease is through 
characterizing the spectrum of psychotic-like experiences in healthy individuals (Zammit et al., 
2013). Although psychosis occurs within various psychiatric disorders, psychotic-like 
experiences also occur in healthy individuals across development (Schlosser et al., 2012; 
Unterrassner, Wyss, Wotruba, Haker, & Rössler, 2017). When psychosis is present in mental 
illness, it contributes to marked changes in behavior, high levels of distress, and significantly 
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impact daily functioning (Paolo Fusar-Poli, Borgwardt, et al., 2013). However, perceptual 
aberrations alone are not necessarily associated with ill mental health (Goulding & Odehn, 
2009). As many as 3% of individuals report psychotic-like experiences regularly, and 7% of 
individuals report a lifetime prevalence of psychosis experiences (Linscott & van Os, 2013). As 
many as 13.2% of the general population endorses hearing voices (Beavan, Read & Cartwright, 
2011). These experiences include perceptual abnormalities (PA), which involve perceiving 
stimuli without an actual percept, as well as hallucinations, in which the experience of PA is 
accompanied by a strong belief in the reality-basis of these percepts without supporting evidence 
(Tucker et al., 1969). Understanding the phenomenology of psychosis on a continuum has 
important implications for uncovering factors that contribute to increased risk of conversion to a 
psychotic disorder, and characterizing potential overlap in underlying neurobiology of low level 
perceptual abnormalities and hallucinations (Powers et al., 2019; Unterrassner, Wyss, Wotruba, 
Ajdacic-Gross, et al., 2017). Furthermore, this approach may suggest new avenues for 
prevention, early intervention, and treatment (Addington, Addington, Abidi, Raedler, & 
Remington, 2017).  
Perceptual abnormalities can include experiences such as hearing one’s name being called, 
seeing shadows in the shape of a person, experiencing the sensation of a cell phone vibrating in 
one’s pocket or hearing song lyrics (Marshall et al., 2019). Adolescence through young 
adulthood marks the prototypical period of symptom onset (Tor et al., 2018).  For these 
individuals at clinical high risk, approximately 25% - 35% will eventually convert to a psychotic 
illness (Addington et al., 2015; Cannon et al., 2008), with approximately one-third converting in 
the first year after onset, another third in the second year, and the final third more than two years 
after onset (Powers et al., 2019). Yet for some, these experiences continue into adulthood 
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without accompanying distress or functional impairment (Pinheiro, Schwartze, & Kotz, 2018; A 
R Powers & Corlett, 2018). For another subset of individuals, attenuated psychotic symptoms 
remit completely (Addington et al., 2019; Simon et al., 2013). Characterizing clinical and 
neurobiological characteristics that distinguish these groups at onset could greatly improve 
targeted early intervention efforts.  
Auditory perceptual abnormalities may be especially important from a phenomenological 
perspective for understanding conversion risk given that auditory verbal hallucinations occur in 
60-80% of all patients with schizophrenia (Shergill et al., 1998). Understanding the continuum of 
shared neurobiology of perceptual abnormalities and auditory hallucinations will help provide 
new understanding of risk factors for conversion, and may lead to improvements in early 
detection and prevention. Yet linking the spectrum of psychotic-like symptoms to neurobiology 
may require a computational and cognitive neuroscience perspective (Adams, Stephan, Brown, 
Frith, & Friston, 2013; Corlett, Frith, & Fletcher, 2009; Sterzer et al., 2018). Bayesian 
approaches to perceptual learning suggest that these experiences are not simply passive 
processes, but rather may be informed by previous conditioning (Corlett et al., 2009). Higher 
order beliefs in the reality basis of these experiences is one of the distinguishing characteristics 
between perceptual illusions versus hallucinations (Teufel et al., 2015). Under a predictive 
coding approach, hallucinations occur when top-down priors beliefs about perceptual 
experiences are maintained without conforming sensory input, resulting in the creation of a 
sensory input that conforms with prior beliefs (Powers, Mathys, & Corlett, 2017; Sterzer et al., 
2018). New computational approaches (Mathys, 2017; Mathys et al., 2014) allow for behavioral 
and physiological data to be leveraged for modelling higher-order beliefs to confirm whether 
perceptual experiences are informed by differences in the weighting of prior expectations versus 
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sensory input. It also provides a powerful tool for linking the neurobiology of perception and 
cognition with systems-level approach to the phenomenology of psychosis across a continuum.  
Neurobiology of Hallucinations and Perceptual Abnormalities  
  Initial evidence suggests that conversion risk may be reflected in both the overlapping 
neural basis of hallucinations and in the neurocognitive impairments that characterize psychosis. 
The neurobiology of hallucinations has increasingly shifted toward emphasizing the role of 
altered N-methyl-D-aspartate (NMDA) receptor functioning (Horga & Abi-Dargham, 2019; A R 
Powers, Gancsos, Finn, Morgan, & Corlett, 2015). Converging evidence from basic and clinical 
research indicate that NMDA receptor antagonists, such as Ketamine, can model both the 
phenomenology and neurobiology of hallucinations (Marsman et al., 2013; Powers et al., 2015). 
NMDA receptor antagonists induce auditory perceptual abnormalities in healthy individuals 
(Krystal et al., 1994) and increase the frequency and intensity of auditory hallucinations in 
patients with psychosis (Kantrowitz & Javitt, 2012). These effects are most likely achieved 
through the role of NMDA receptor antagonists in increasing the release of the neurotransmitter 
glutamate through the inhibition of GABAergic interneurons (de Jonge, Vinkers, Hulshoff Pol, 
& Marsman, 2017; Kittelberger, Hur, Sazegar, Keshavan, & Kocsis, 2012; Paoletti, Bellone, & 
Zhou, 2013) Specifically, NMDAR hypofunction increases activation of top-down frontal 
activity, including  the anterior cingulate cortex (ACC), which results in the suppression of 
sensory signaling through primary sensory areas (Ranson et al., 2019).  In animal models, both 
the acute and chronic administration of NMDA receptor antagonist reliably reproduce the 
neurobiological abnormalities observed in the pathology of psychosis (Cordon et al., 2015; 
Kittelberger et al., 2012; Kort et al., 2017; Michaels, Long, Stevenson, Chrobak, & Chen, 2018). 
This includes reduction in the number of GABAergic interneurons in hippocampal regions 
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(Cunningham et al., 2006), increases in anterior cingulate cortex glutamate levels (Stone et al., 
2014) and decreased synaptic plasticity in the prefrontal cortex (Zhang, Behrens, & Lisman, 
2008). Several studies (Kokkinou, Ashok, & Howes, 2018; Stone et al., 2010; White et al., 2018) 
have demonstrated that cortical NMDAR hypofunction results in other neurobiological 
abnormalities consistently reported in psychosis, including increased striatal dopamine release 
(Kokkinou et al., 2018; Stone et al., 2010). However, given the complex interaction of these two 
neurotransmitter symptoms, (McCutcheon, Krystal, & Howes, 2020) and mixed findings 
regarding their role across different clinical aspects of psychotic illness, more evidence is needed 
to further characterize the effects of NMDA hypofunction on subcortical dopamine in the 
etiology of hallucinations. 
 In vivo studies of glutamate and GABA levels in individuals with psychosis provide 
further evidence of the putative role of NMDA hypofunction in the neurobiology of 
hallucinations (Kegeles et al., 2012; Rowland et al., 2013). 1H magnetic resonance spectroscopy 
(1H-MRS or MRS) is a neuroimaging technique that assesses the chemical composition of 
tissues in a noninvasive manner by using the magnetic resonance of hydrogen to determine the 
concentration of metabolites (Chiappelli, 2018; Cohen & Sweet, 2011; Faro, Mohamed, Law, & 
Ulmer, 2012). MRS allows for the in vivo measurement of various metabolites, including 
glutamate (Glu), GABA, glutamine, or the combination of glutamate and glutamine 
(Glx)(Dhamala et al., 2019). A meta-analysis of 1H- MRS studies (Marsman et al., 2013) in 
patients with psychosis compared to healthy controls reported increased levels of glutamate in 
the medial prefrontal cortex. Individuals with first-episode psychosis appear to have increased 
level of glutamate in the anterior cingulate cortex compared to healthy controls, and glutamate 
levels in frontal regions are positively correlated with psychosis symptom severity (Kegeles et 
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al., 2012). Unmedicated patients with first-episode psychosis also demonstrate increased Glu 
levels in the ACC (Poels et al., 2014).  
 Findings from MRS studies investigating glutamate levels in those at clinical high risk 
(CHR) for psychosis are somewhat mixed. Several studies report no differences in the level of 
glutamate (Fusar-Poli et al., 2011; Stone et al., 2009) or Glx (Keshavan et al., 2009; Purdon, 
Valiakalayil, Hanstock, Seres, & Tibbo, 2008; Yoo et al., 2009) between CHR and health 
controls. One study reported increased levels of Gln (Stone et al., 2009) and another increased 
Glu/Gln ratio (Tibbo et al., 2004) in high-risk unmedicated individuals compared to controls. A 
large multi-year study of CHR individuals (Addington et al., 2007, 2012) that includes a MRS 
neuroimaging component is currently being completed at several sites across North America and 
will likely contribute significantly increased sample in order to provide additional power to 
detect between-group differences in glutamate levels.  
 Fewer studies have examined alterations in GABA in high-risk, first-episode, or chronic 
patients with psychosis. Increased GABA levels have been reported in chronic patients with 
psychosis (Choe et al., 1994) and after four-to-six months of antipsychotic medication treatment 
(Choe et al., 1996). MRS studies of individuals high in schizotypal traits demonstrated increased 
levels of glutamate and decreased GABA levels relative to health controls (Fervaha & 
Remington, 2013; Lin et al., 2012) but such differences may be task-dependent (Duncan, Enzi, 
Wiebking, & Northoff, 2011). Two studies (Rowland et al., 2013 and Rowland et al., 2015) 
report decreased GABA concentrations in chronic patients, another (Ongur et al.) reported 
increased GABA in the anterior cingulate of chronic patients.  
Two recent meta-analyses (Egerton, Modinos, Ferrera, & McGuire, 2017; Kumar, Vajawat, 
& Rao, 2020) examined GABA levels in chronic patients with psychosis and in CHR 
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individuals. In patients with schizophrenia, GABA levels were lower in the anterior cingulate 
cortex compared to healthy controls, but there were no between-group differences in other 
frontal regions (Kumar et al., 2020). Yet when comparing CHR individuals to healthy controls, 
there were no between-group differences across all MRS studies (Egerton et al., 2017) nor in 
studies using other neuroimaging techniques including positron emission tomography (PET) and  
single photon emission computed tomography (SPECT). Two separate studies (Wang et al., 
2016; Modinos et al., 2018) report no difference in GABA levels in those at ultra-high risk for 
psychosis (those with clinical risk factors and a family history of psychosis), while one study (Da 
Silva et al., 2019) reported higher GABA levels in those at clinical risk and another (de la 
Fuente-Sandoval et al., 2016) in those at ultra-high risk. These mixed results suggest the need for 
additional studies investigating the role of prefrontal GABA levels in the prodromal stages of 
psychosis. 
 There are several potential explanations for the above-noted discrepancies across MRS 
studies. There is some evidence that antipsychotic medications decrease glutamate levels 
(Schwerk, Alves, Pouwels, & van Amelsvoort, 2014), including in the ACC. Between-study 
differences in magnetic field strength may also contribute to mixed findings. There are many 
methodological differences across studies that could impact the ability to detect differences, 
including voxel size, voxel placement, and pulse sequence parameters. Few studies controlled for 
differences in white matter and CSF volume and none of the studies compared findings to a 
control region. Comparison across MRS studies examining differences in GABA levels is 
especially difficult given the need for using J-editing techniques that distinguish GABA from 
overlapping signals of other metabolites (Mikkelsen et al., 2017). When GABA MRS procedures 
are implemented in a standardized fashion, the reliability and consistency of measurement is 
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greatly increased (Mikkelsen et al., 2018). Although GABA concentrations are typically 
referenced to total creatine (TCr) levels, due to its relative stability, there is some evidence that 
phosphocreatine (PCr), which is a large component of the TCr signal, may be altered in disease 
states (Turner & Gant, 2014). Given these challenges associated with measuring glutamate levels 
in medicated individuals, the variability in GABA measurement across studies, and the unclear 
role of glutamate and GABA in clinical high-risk individuals, additional studies are needed to 
further elucidate these proposed neurobiological abnormalities across the spectrum of psychotic 
experiences. 
Dimensional Approaches to Perceptual Abnormalities   
 The endorsement and nature of psychotic-like experiences can be assessed through a 
variety of approaches, including through self-report and structured clinical interview. In help-
seeking populations, the Structured Interview for Prodromal States (SIPS) (Miller et al., 2003) is 
the gold standard for clinical research and can be especially helpful for monitoring conversion to 
psychosis (Cannon et al., 2008; Powers et al., 2019). It collects detailed information regarding 
psychotic experiences including an individual’s level of conviction, distress, and changes in 
behavior in response to PA. Yet the SIPS is time-consuming to administer, is primarily focus on 
current symptoms, has not been normalized in healthy individuals, and was primarily designed 
for use in non-clinical samples (Miller et al., 2002). The Structured Clinical Interview for DSM-
5 Disorders (SCID-5) (First, 2014), while also time-consuming to administer and requiring 
supervised training in administration, has been utilized for both clinical and research purposes 
and maps onto diagnostic criteria in order to rule out a current or past psychotic diagnosis 
(Shankman et al., 2018).  
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 An individual’s predisposition toward experiencing perceptual abnormalities can be 
reliably measured through self-report (Chan et al., 2019; Kim et al., 2010; Kline et al., 2016, 
2012; Ratcliff, Farhall, & Shawyer, 2011). These measures have historically been developed 
using a dimensional approach to understanding psychotic symptoms on a continuum (E. R. 
Peters, Joseph, & Garety, 1995), in contrast to structured clinical interviews that are based on 
discrete risk states (e.g., the SIPS) or categorical diagnostic labels (e.g., the SCID-5). Several 
measures of perceptual abnormalities and psychotic-like experiences have been developed and 
tested for use in healthy individuals (Ratcliff et al., 2011). Yet there is considerable variability in 
the underlying constructs being measured across measures (Unterrassner, Wyss, Wotruba, 
Ajdacic-Gross, et al., 2017). The Launay-Slade Hallucination Scale Revised (LSHS-R) (Bentall 
& Slade, 1985; Launay & Slade, 1981) is a 12-item self-report measure of an individual’s 
propensity to endorse hallucinations. It was designed for use in healthy individuals (Launay & 
Slade, 1981), has strong psychometric properties including test-retest reliability (Waters, 
Badcock, & Maybery, 2003), and has been normed in large undergraduate (Aleman, 
Nieuwenstein, Böcker, & De Haan, 2001) and adolescent (Løberg, Gjestad, Posserud, Kompus, 
& Lundervold, 2019) samples. Previous studies using the LSHS-R provide strong support for 
hallucinations existing on a continuum given the scale’s reliability in measuring this construct 
consistently across healthy individuals (Kråkvik et al., 2015), patients with psychosis, and those 
with a history of hallucinations (Levitan, Ward, Catts, & Hemsley, 1996). The LSHS-R is a 
particularly useful tool for examining current perceptual abnormalities in healthy individuals 
given its utility in being able to reliably track these symptoms in those who covert to psychosis 
and in instances where the persistence of these experiences is not associated with mental illness.  
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 Among adolescents and young adults who experience hallucinations, a portion will not 
covert to a psychotic disorder but may go on to develop a broader constellation of traits 
consistent with or similar to schizotypal personality disorder (STPD) (Rossi & Daneluzzo, 2002). 
STPD is a mental health condition characterized by unconventional beliefs, social difficulties, 
perceptual abnormalities, and paranoia (American Psychiatric Association, 2013). Although the 
prevalence of schizotypal traits is high in CHR individuals, this overlap alone does not influence 
the risk for conversion to psychosis (Zoghbi et al., 2019). While the diagnosis of STPD is 
associated with functional decline and subjective distress, its prevalence in clinical samples is 
low (APA, 2013), perhaps due to a lack of help-seeking behavior in this population (Barkus et 
al., 2010). Indeed, many individuals high in schizotypal traits maintain adequate functioning, and 
there may be a propensity toward this phenotype in certain professions such as psychics 
(Pinheiro et al., 2018; Powers, Kelley, & Corlett, 2017), mediums, and shamans (Powers & 
Corlett, 2018).  
 The Schizotypal Personality Questionnaire (SPQ) is a 75-item self-report questionnaire of 
schizotypal traits in the general population (Raine, 1991). The SPQ has strong psychometric 
properties (Callaway, Cohen, Matthews, & Dinzeo, 2014; Fonseca-Pedrero, Cohen, Ortuño-
Sierra, de Álbeniz, & Muñiz, 2017), has been tested and normed extensively in undergraduate, 
young adult, and nonclinical samples (Rossi & Daneluzzo, 2002; Unterrassner, Wyss, Wotruba, 
Ajdacic-Gross, et al., 2017; Unterrassner, Wyss, Wotruba, Haker, et al., 2017), and is consistent 
with clinician ratings of schizotypal traits in healthy individuals without personality disorders 
(Chan et al., 2019). Unlike other self-report measures that are limited to PA, subscales of the 
SPQ also measure cognitive symptoms consistent with the prodrome of psychosis(Axelrod, 
Grilo, Sanislow, & McGlashan, 2001; Callaway et al., 2014; Compton, Goulding, Bakeman, & 
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McClure-Tone, 2009; Fonseca-Pedrero et al., 2017; Yaralian et al., 2000). The combined 
cognitive-perceptual factor of the SPQ can therefore provide a strong indication of traits related 
to the cognitive and perceptual abnormalities that are common across CHR, SZ, and STPD 
individuals.   
  While there are currently significant clinical and research efforts aimed at identifying 
factors that predict conversion to psychosis from prodromal states, few self-report measures of 
perceptual abnormalities have been examined with respect to their predictive validity. The 
Chapman Perceptual Aberration Scale (Chapman, Chapman, & Raulin, 1978), is a 35-item self-
report questionnaire that assesses psychotic-like experiences such as unusual perceptual 
abnormalities, bodily sensations, and dissociation. It has strong predictive abilities across time 
and cultures (Chan et al., 2015; Chapman, Chapman, Kwapil, Eckblad, & Zinser, 1994), and 
maps onto other measures of schizotypal traits. As many as 10% or more of CHR individuals 
who convert to a psychotic disorder are diagnosed with an affective form of psychosis such as 
bipolar disorder with psychotic features or major depressive disorder with psychotic features 
(Paolo Fusar-Poli, Bechdolf, et al., 2013).  Previous studies (Chapman et al., 2020) demonstrate 
that the Chapman scales may be especially useful for capturing the co-occurrence of mood and 
perceptual symptoms.  
 Cognitive models of auditory hallucinations propose that the persistence of these 
experiences is mediated by one’s beliefs (Garety & Hemsley, 1987). Delusions are tenaciously-
held false beliefs that can include strongly held convictions related to the experience of 
perceptual abnormalities. In line with the fully dimensional view of psychotic symptoms, and the 
role of beliefs and expectation in the formation of these experiences, the Peters et al. Delusions 
Inventory (PDI) is a 21-item self-report measure that assess an individual’s distress, 
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preoccupation, and conviction associated with various delusional beliefs (Peters & Garety, 1996; 
Peters et al., 1995). The measure has strong psychometrics properties and has been used in large 
samples of healthy individuals (Peters, Joseph, & Garety, 1999), patients with psychosis (Peters, 
Day, McKenna, & Orbach, 1999), and undergraduate population (Fonseca-Pedrero, Paino, 
Santarén-Rosell, Lemos-Giráldez, & Muñiz, 2012).  
Cognitive Impairment in the Prodrome of Psychosis  
 Cognitive deficits are a well characterized clinical feature of psychotic illness (Goldberg, 
David, & Gold, 2003; Green, 1996; Green, Kern, Braff, & Mintz, 2000). Recent efforts to 
identify and treat CHR individuals have focused on the neurocognitive profile of these 
individuals including variability in cognitive abilities and related functioning at the onset of 
symptoms, during the prodrome, and upon conversion to psychosis (Addington, Liu, et al., 
2017). Changes in cognition may not only be related to risk for conversion, but may precede 
frank psychotic symptoms (Fusar-Poli et al., 2012)and therefore may be especially important for 
early detection and prevention efforts.  
 CHR individuals who convert to psychosis on average have a lower full-scale IQ and 
lower processing speed compared to those who not convert (Seidman et al., 2012). For a subset 
of individuals, the onset of reduced processing speed occurs prior to the onset of attenuated 
psychotic symptoms. Other studies (Addington, Liu, et al., 2017; Seidman et al., 2010) have 
demonstrated working memory deficits and difficulties with verbal memory as markedly 
impaired in CHR individuals and a strong predictor of eventual conversion.  The Digit-Symbol 
Coding subtest (Coding) of the Weschler Abbreviated Scale of Intelligence (WAIS-IV) 
(Weschler, 2010) is a well-validated and commonly-used measure of processing speed that has 
been tested in patient populations, large adult populations, and undergraduate samples (Cornelis 
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et al., 2014). Poor performance on this neuropsychological measure is associated with worse 
functioning in psychotic illness, and predicts the later severity of symptoms (Fusar-Poli et al., 
2012). The Letter-Number Sequencing task (LNS) is a measure of working memory abilities that 
has been validated across several large samples, is known to be impaired in psychosis (Gold, 
Carpenter, Randolph, Goldberg, & Weinberger, 1995), and is correlated with positive symptom 
severity (Haut, Kuwabara, Leach, & Arias, 2000; Hurford, Marder, Keefe, Reise, & Bilder, 
2011; Murtagh et al., 2010). The strong reliability and validity of both measures, their use in 
clinical and non-clinical samples, their ease of administration, and their relation to psychosis 
symptom emergence and severity, indicate strong ability to detect neurocognitive differences that 
relate to underlying neurobiological vulnerability to psychosis.     
Predictive Coding Account of Psychosis   
  Perceptual experiences are not merely passive “bottom-up” processes but rather are 
informed by higher-order learning (Rao & Ballard, 1999; Seymour, 2004). This is supported by 
evidence that individuals infer the cause of sensory information (von Helmholtz, 1867).  For 
example, the sensation of being tickled can be cancelled when anticipated, either from someone 
else or oneself. In order to successfully navigate the world, perceptual experiences are learned 
and inform expectations about future sensory experiences. These models of the world are 
updated when novel perceptual information conflicts with previously learned expectations 
(Adams et al., 2013; Sterzer et al., 2018). The accuracy of these predictions must be robust 
enough to resist change yet flexible enough to adaptively incorporate new sensory information. 
This predictive coding account of perception relies on the mathematical approach of Bayesian 
inference (Corlett et al., 2009). A sensory prediction is represented as a probability (prior) and is 
combined with incoming sensory data (likelihood, also represented as a probability) to create a 
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posterior probability, which reflects the most likely outcome based on prior predictions and 
current sensory experience (Sterzer et al., 2018).  
As a theory of brain function, predictive coding provides an account of hierarchical sensory 
learning in which low level sensory predictions contribute to higher-order beliefs or schemas 
about the perceptual world (Corlett et al., 2009; Horga, Schatz, Abi-Dargham, & Peterson, 
2014). Prediction errors occur when incoming data violates prior predictions (i.e., the difference 
between the mean of the prior and the mean of likelihood probabilities). The reliability of priors 
vs. sensory data is based on their respective weighting (Mathys et al. 2011). The overweighting 
of priors or incoming sensory data can result in erroneous updating of internal working models 
of the world or the creation of percepts that conform with expectations. If previously learned 
associations and experiences are maintained in the absence of incoming sensory data (increase 
precision of a prior belief), a percept is created that conforms with previous expectations (i.e., 
hallucination). If sensory data are too easily incorporated into internal working models 
(increased precision of sensory data), individuals develop strongly held beliefs that resist change 
(i.e., delusions)(Anandakumar, Connaughton, Coltheart, & Langdon, 2017; Corlett et al., 2009; 
Corlett, Taylor, Wang, Fletcher, & Krystal, 2010)                 .   
Preliminary evidence provides support for hallucinations relying on disruption in the 
weighting of prior beliefs. Yet it is unclear whether such weightings are disrupted at different 
hierarchical levels. enhanced top-down signaling and increased precision of priors. Individuals 
who hear voices demonstrate reduced bottom-up connectivity from Wernicke’s to Broca’s area 
(Friston, 2005) and hallucinators are more susceptible to sensory conditioning, which has been 
associated with an overweighting of prior beliefs (Powers, Mathys & Corlett, 2017). When 
auditory information is uncertain, hallucinators are biased toward responding in a manner that is 
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consistent with a stronger weighting of prior beliefs (Cassidy et al., 2018). This bias could also 
be induced through the administration of amphetamines, consistent with the well-established role 
of striatal dopamine in the etiology of psychosis.  Yet other evidence suggests that auditory 
verbal hallucinations (AVH) rely on weak priors given evidence that individuals who experience 
AVH are inaccurate in predicting the sensory consequences of internal speech (Horga & Abi-
Dargham, 2019; Kort et al., 2017).  
Predictive coding provides a computational framework for linking the phenomenology of 
hallucinations with the neurobiology of psychosis. GABA and glutamatergic functioning appear 
critical to the E/I balance.  but perhaps differentially across the hierarchy of the brain. Weak 
priors at lower levels (primary sensory regions) may lead to relying on high-level abstract or 
semantic prior beliefs. A decrease in the precision of priors may be related to glutamatergic 
hypofunction and its effects on striatal dopamine release (Teufel et al., 2015).  Ketamine and 
other NMDA antagonists alters excitatory/inhibitory balance (Jardi & Deneve, 2013). This is 
supported by evidence that perceptual abnormalities can be conditioned; when trained to 
associated a light with a tone, individuals who experience hallucinations were more likely to 
endorse perceiving the tone when the light was presented alone than those who do not experience 
hallucinations (Powers, Mathys & Corlett, 2017). 
Predictive coding is consistent with several adjacent theories of hallucinations.  Although 
individuals with psychotic disorders were especially susceptible to this effect (Kot & Serper, 
2002), individuals without a diagnosed psychotic illness but who experience PA also endorsed 
conditioned hallucinations during the task, suggesting a common mechanism between 
pathological and phenomenological hallucinations. Individuals who experience perceptual 
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aberrations attribute importance to events that others would not find salient, a process that can be 
viewed as a form of prediction error (Kapur, 2003).  
Functional neuroimaging data of conditioned auditory percepts indicate that when making 
correct rejections, hallucinators were less likely to engage the anterior cingulate cortex (ACC) 
compared to non-hallucinators (Powers, Mathys & Corlett, 2017). The ACC has been 
consistently implicated in both the neural activity of auditory verbal hallucinations (Zmigrod, 
Garrison, Carr, & Simons, 2016) as well as stimulus detection prediction (den Ouden et al., 
2009) and audiovisual associative learning (Laurienti et al., 2003). It is involved in cognitive 
control (Barch, 2017) and in source monitoring of censoring information (Yeung & 
Nieuwenhuis, 2009). Yet the neurobiological underpinning of these ACC activation differences 
is largely unknown.  
Current Investigation 
The present study investigated the neurobiology of conditioned hallucinations through the 
use of MRS to collect in-vivo measurements of glutamate and GABA neurotransmitter levels in 
healthy individuals that vary in their endorsement of perceptual abnormalities. When compared 
to individuals who do not experience PA (STP- or minus), individuals who endorse PA 
consistent with schizotypal personality traits (STP+ or plus), will 1) be more likely to endorse 
false percepts (conditioned hallucinations), 2) will be more confident in their belief about the 
conditioned hallucinations, 3) will demonstrate differences in fMRI activation patterns consistent 
with the neurobiology of hallucinations, and 4) will demonstrate increased glutamate 
concentrations (as measured by the ratio of total glutamate to total creatine) and decreased 
GABA concentrations (as measured by the ratio of total GABA to total creatine) in the ACC 
compared to glutamate and GABA concentrations in a control region (paracentral lobule). 
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Through applying a predictive coding account of conditioned hallucinations in a healthy 
undergraduate sample, the present investigation aimed to provide further support for the top-
down role of perception in psychotic experiences along a continuum, as well determine whether 
the neurobiological and cognitive mechanisms underlying perceptual aberrations overlap with 
the putative role of NMDA receptor hypofunction in psychosis.  
Methods 
All study materials, participant recruitment and protocol procedures were approved by 
the Institutional Review Board (IRB) of the Human Research Protection Program (HRPP) at the 
University of Connecticut. All participants had the opportunity to read and discuss the consent 
form and all participants provided informed consent before participating. Two groups of 
participants were recruited: 1) individuals without a diagnosable psychiatric disorder who 
endorse schizotypal traits (STP Plus/STP+) and 2) healthy individuals without a diagnosable 
psychiatric disorder who do not endorse schizotypal personality traits (STP Minus/STP-).  Study 
recruitment occurred in two parts; during the first part (Phase A), participants were invited to 
participate in an online survey through the Department of Psychological Sciences participant 
pool. Those survey participants who met study criteria from Phase A were invited to the second 
part of the study (Phase B) which included an in-person screening visit.  If eligible following the 
in-person screening visit, participants were enrolled in the neuroimaging portion of the study. In 
addition to recruitment through the Participant Pool, Phase B participants were also recruited 
though online and local advertisements in Storrs, Connecticut and Hartford, Connecticut. For 
Phase B, exclusion criteria were as follows for all participants: 1) current diagnosis of an Axis I 
psychiatric disorder (including psychotic disorders); 2) MRI contraindications and 
claustrophobia; 3) subject-reported substance dependence or active use; 4) pregnancy or 
possibility of pregnancy by self-report; 5) any medical or developmental problem that is known 
 18 
to impair cognition significantly such as intellectual disability, attention deficit hyper activity 
disorder, Huntington’s disease, Down Syndrome, or traumatic brain injury; 6) individuals with 
significant hearing impairment including those requiring the use of a sign-language translator; 
and 7) individuals with significant vision impairment such that they are unable to able to read the 
third line of a standard eye chart (with corrected vision).  
Participants (Phase A) 
The overall sample was comprised of 552 individuals, 98% of whom (542) were 
undergraduate students enrolled in introductory psychology courses at the University of 
Connecticut. Exclusion criteria for Phase A participants were as follows: 1) Self-reported first-
degree relative with history of a diagnosed psychotic disorder (e.g., schizophrenia, 
schizoaffective disorder, major depressive disorder with psychotic features, or bipolar disorder 
with psychotic features), 2) MRI contraindications and claustrophobia; 3) non-native English 
speakers and 4) incomplete survey response data. Based on the above-mentioned criteria, 173 
participants (31%) provided incomplete data and were excluded from further enrollment. Of the 
remaining sample (n=379), a total of 137 survey participants (36%) were excluded based on the 
following: first degree relative with psychiatric diagnosis (n=105, 27%), non-native English 
speaker (n=21, 5%), MRI incompatibility (n=11, 2%). The remainder of the sample (n=242, 
43%) were deemed eligible to continue and were invited via email to participate in Phase B of 
the study. Among those participants eligible from Phase A, participants with a LSHS total score 
above 20 (n=51, 21% ) were classified into the STP+ group while those with LSHS total scores 
below 20 (n=191, 78% were classified into the STP- group. The LSHS total score of 20 was 
selected based on previous research demonstrating this score as approximating the median split 
in college student samples (Aleman et al., 2001; Waters et al., 2003).  
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Survey Measures (Phase A) 
Participants in Phase A of the study completed several self-report measures including 
those that were utilized to determine their eligibility for Phase B. This included demographic 
information (e.g., sex, ethnicity, gender, age, and years of education), family history of psychosis 
diagnosis, language abilities, contraindications for MRI, and questions related to hearing or 
visual difficulties, Perceptual abnormalities were assessed using several different self-report 
measures. The Chapman Perceptual Abnormality Scale (Chapman et al., 1978) consists of 35 
items that assess experiences such as bodily discontinuities and unusual sensory experiences. It 
has been validated in a large population of undergraduate students for the assessment of 
psychotic experiences (Chapman et al., 1994). The Peters Delusion Inventory (PDI) is a 21-item 
scale measure (Peters & Garety, 1996) of delusional beliefs that includes subscales of distress, 
preoccupation and conviction.. It has been validated in an undergraduate sample (Fonseca-
Pedrero et al., 2012). The Schizotypal Personality Questionnaire (SPQ) is a 75 item self-report 
questionnaire modeled on DSM-IV TR criteria for Schizotypal Personality Disorder (SPD) that 
contains subscales for all nine schizotypal traits (Callaway et al., 2014). The measure has been 
used extensively in assessing the screening for SPD in both clinical (Chan et al., 2019; Raine, 
1991) and healthy individuals (Unterrassner, Wyss, Wotruba, Haker, et al., 2017). The Launay-
Slade Hallucinations Scale (LSHS-R) is a 12-item measure frequently used to detect 
predisposition to hallucinations in normal individuals (Launay & Slade, 1981). It assesses three 
factors include vivid mental events, hallucinations with a religious theme, and auditory and 
visual hallucinations experiences (Aleman et al., 2001; Waters et al., 2003).   
Participants (Phase B) 
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All participants that met inclusion criteria based on Phase A survey data were invited to 
participate in Phase B of the study. Twenty-three individuals completed in-person screening 
during Phase B, 12 individuals in the STP- group and 11 individuals in the STP+ group. Ten 
participants (66%) from the STP- group screened-in, and six of the 11 (54%) STP+ participants 
met inclusion criteria. Two of the eight (25%) STP+ participants that screened-in were lost to 
follow-up when scheduling the fMRI portion of the study; all of the eligible STP- participants 
continued to the second part of the study (Figure 1). Within the STP- group, one individual 
(16%) did not complete the fMRI due to a software error. MRS data for the control region were 
not collected in two of the nine (22%) participants from the STP- group due to time limitations 
and poor fit quality (Figure 1). In total, 15 participants completed Phase B procedures, 13 of 
whom (86%) completed all study procedures and provided both task and MRS data for analysis. 
Clinical and Neuropsychological Assessments (Phase B) 
During the first visit of Phase B, participants were screened through administration of the 
Structured Clinical Interview for the Diagnosis of DSM-IV-R disorders (SCID-IV) (First et al., 
2002) to exclude any individuals that meet criteria for a current psychiatric disorder. Six of the 
23 participants (26%) enrolled in Phase B (three participants in each group) were excluded due 
to currently meeting criteria for the following psychological disorders: Attention-
Deficit/Hyperactivity Disorder (n=1), Bipolar Disorder (n=1), Generalized Anxiety Disorder (n= 
2), and Major Depressive Disorder (n=2). The remaining individuals (n= 15) were enrolled in the 
final phase of the study (Phase B).   
To estimate participants’ overall cognitive abilities, participants were administered the 
two-subtest form (Vocabulary and Matrix Reasoning subtests) of the Weschler Abbreviated 
Scale of Intelligence, Second Edition (WASI-II). The two-test version of the WASI-II provides a 
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brief, reliable measure of verbal and perceptual reasoning abilities in order to estimate overall 
cognitive abilities (Weschler, 2013). The WASI-II has strong psychometric properties (Dumont 
& Willis, 2008) and has been used in both clinical and research settings (Holdnack, Schoenberg, 
Lange, & Iverson, 2013; McCrimmon & Smith, 2013). Participants also completed additional 
neuropsychological measures including Letter Number Sequencing (LNS) and Digit Symbol 
Substitution Test (DSST). LNS is a measure of numeric working memory and demonstrates 
superior psychometric properties (Murtagh et al., 2010). It has been specifically investigated in 
patients with psychotic illness (Hurford et al., 2011) and correlates strongly with the severity of 
positive symptoms (Addington, Liu, et al., 2017; Haut et al., 2000). DSST is a timed measure of 
oral and visual processing speed that has been validated in a large normative sample and has 
strong psychometric properties (Lezak, Howieson, & Loring, 2004). Both patients with psychosis 
(Cornelis et al., 2014) and those with attenuated psychotic symptoms (Paolo Fusar-Poli et al., 
2012) show reduced processing speed performance on the DSST.  
fMRI Task and Behavioral Data 
All stimuli were presented and responses were recorded through MATLAB Psychtoolbox 
3.0 (Hernández Lorca, 2018; Kleiner et al., 2007). A white fixation cross was presented on a 
black background throughout each run. The visual stimuli consisted of a 4 x 7 square gray and 
black checkerboard pattern. Gray squares were presented at 25% brightness to maximize visual 
stimulation. The target auditory stimuli consisted of a 1-kHz tone with a 100-ms ramped 
envelope presented with a broadband white noise (130dB PSL). Scanner noise was estimated by 
sound-level meter to be at 130dB SPL. Participants were provided with in-ear headphones with 
foam earplugs for protection from scanner noise. The attenuation afforded by the headphones 
was deemed to be 40dB SPL and therefore target stimuli were adjusted to be presented at 90 dB 
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PSL to account for the attenuation. During the task, target tones were presented at 0% (no tone), 
25%, 50% and 75% likelihood of detection as determined by the QUEST thresholding paradigm.  
Participants who screened-in Phase B Part 2 practiced the condition hallucination task 
outside the scanner on a 2017 Apple MacBook Pro laptop with a pair of AKG (Vienna, Austria) 
K240 Professional Studio headphones prior to completing the task in the scanner. The task was 
run in Matlab Version 2018b through the PsychToolbox 3.0. Task instructions were provided 
verbally and participants were tested on their understanding of task instruction during the 
practice run. The practice session used the same stimuli, task components, and scanner noise as 
the fMRI component. During the practice component, participants responded whether the 
auditory stimuli was present as well as their confidence in their response and were required to 
achieve over 85% accuracy to continue in the study.   
During the fMRI portion of the study, participants completed stimulus thresholding prior 
to test runs using the QUEST maximum-likelihood-based procedure (Watson & Pelli, 1983). 
Threshold testing determined the stimulus intensity threshold for 75% likelihood of detection of 
target stimulus embedded in noise for each participant. Individual psychometric curves were 
fitted given participants responses, and stimulus intensity of 25% and 50% detection were 
derived based on these psychometric curves. During the main test trials of the experiment, target 
tones were presented at levels estimated to correspond to these (75%, 50%, and 25%) likelihoods 
of detection. Total trial length during the thresholding procedures was 2500ms. Training trials 
establish a relationship between a conditioned stimulus (a clearly-presented 4x7-square 
checkerboard pattern, gray on black, presented at 25% brightness), and the unconditioned 
stimulus (a 1-kHz tone with 100-ms ramped envelope with broadband white noise presented at 
130dB SPBL). Training trials consists of the presentation of a fixation (500-1000ms form trial 
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start) followed by presentation of the visual stimulus concurrent with the auditory stimulus for 
one second.  
Test trials consisted of 12 blocks of 30 trials over 3 blocks per functional run. Unlike 
training trials, test trials included target-absent trials (0% threshold) in which the unconditioned 
stimulus was not presented. Trial-type relative likelihoods were determined by block number and 
trial type presentation was pseudorandomized within block. During the QUEST procedure, 
participants reported report whether the tone was present or not present. During training and test 
trials, participants reported whether the tone was present and how confident they were in their 
answer on a scale from 0 (not confident) to 5 (very confident) over a 2000-ms response period 
(Figure 2). Positive responses in the absence of the unconditioned stimulus were considered a 
hallucinated percept. When responses were not recorded in time, the stimulus intensity 
corresponding to that trial was repeated during the next trial.  
MRS Data Collection  
All MRI procedures were conducted on a Siemens Prisma 3 Tesla scanner (Berlin, 
Germany) with a 64-channel head coil at the University of Connecticut Brain Imaging Research 
Center (Storrs, CT). ECG and respiration recordings were conducted using an MRI-compatible 
equipment. Participants were provided with in-ear noise-cancelling headphones that ran through 
a Silent Scan audio system (Avotec, Stuart, FL) and were provided a 1x2 response box (Current 
Designs, Inc., Philadelphia, PA) in their right hand for the task. The task was presented through 
the Psychtoolbox application in MATLAB Version R2018a (MathWorks, 2018) running on a PC 
and projected onto a 24" BOLDscreen LCD display viewed through a double mirror fitted to the 
head coil (Cambridge Research Systems, Kent, UK). Prior to running participants, in-scanner 
noise was measured and used to calibrate the decibel output of task audio stimuli.  
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Participants completed Localizer, Field Map A/P and Field Map P/A scan sequences 
prior to fMRI and MRS scans. Three-dimensional high-resolution anatomical scans were 
acquired using a magnetized prepared rapid acquisition gradient echo (MPRAGE) pulse 
sequence (Echo time [TE] = 2.98ms, Repetition time [TR] = 2300ms, Flip angle [FA] = 9°, 
number of excitations [NEX] = 2) that produced 176 T1-weighted images with a field of view 
(FOV) of 26cm and voxel sizes of 1.0 x 1.0 x 1.0mm. Participants were instructed to keep their 
head still and watched a movie of their choice during these initial scans. During the task, a 
multiband (factor=3) pulse sequence was run (Echo time [TE] = 30.20ms, Repetition time [TR] 
= 1070ms, Flip angle [FA] = 57°, number of excitations [NEX] = 2) that produced 60 slices with 
a field of view (FOV) of 210mm and voxel sizes of 2.5 x 2.5 x 2.5mm. The thresholding 
procedure was five minutes long while training and test trials lasted approximately 40 minutes 
(four nine-minute runs).  
For the MRS portion of the task, voxel templates were created through the Voxel 
Positioning System (Hancock, 2019) pipeline in ParaView (Kitware, Clifton Park, NY), an open-
source, multi-platform data visualization application. The dimensions for the MRS volumes of 
interest (VOI) were as follows: (1) anterior cingulate cortex (ACC): size 24 x 24 x 21 mm, and 
(2) paracentral lobule (PCL): size 20 x 20 x 20mm. The median sagittal plane was selected as a 
reference slice for voxel positioning. All of the VOIs were positioned in such a manner as to 
avoid the ventricles and skull and minimize the percent white matter and CSF in the VOI. 
Manual adjustments were applied for each participant to ensure that the Full Width Half Max 
(FWHM) of the spectral peak was below 25 Hz.  A Point Resolved Spectroscopy Sequence 
(PRESS) sequence (Yahya, Mädler, & Fallone, 2008) was used for glutamate detection (Mullins, 
2008) with the following parameters: TR = 2000 ms; TE = 40 ms; 128 signal averages; 
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acquisition bandwidth = 2000 Hz. A symmetric-suppression (Mullins et al., 2014) Mescher-
Garwood Point Resolved Spectroscopy Sequence (MEGA-PRESS) (Baeshen et al., 2019; 
Dhamala et al., 2019; Mullins et al., 2014) was used for GABA detection with the following 
parameters: TR = 2000 ms; TE = 80 ms; 64 signal averages; acquisition bandwidth = 2000 Hz. 
During odd-numbered acquisitions, a frequency-selective, Gaussian inversion pulse was applied 
to GABA-3CH2 resonance at 1.9 ppm, affecting the weakly J-coupled triplet peak of GABA-
4CH2 at 3.01 ppm (EDIT-ON). During even-numbered acquisitions, the same pulse was applied 
at 1.5 ppm, symmetrically to the 1.7 ppm coupled macromolecule spins (EDIT-OFF). The 
GABA-edited spectrum was obtained from the difference between the EDIT-ON and EDIT-OFF 
spectra. For quantification, a shorter measurement (16 averages) of the unsuppressed water 
signal from the same volume was obtained. Variable power optimized relaxation delays 
(VAPOR) (Tkacl et al., 1999) were applied for water suppression. Shimming was performed 
automatically before each acquisition. Three consecutive MEGA-PRESS scans were acquired for 
each participant for each region. 
Survey and Behavioral Data Analysis 
 
Survey data were collected and exported from Qualtrics through the University of 
Connecticut’s Psychological Experiment Pool. All survey data was analyzed in R Studio 
(RStudio Team, 2015). Chi-square and unpaired two-sample t-tests were run to examine group 
differences in demographic variables and self-reported levels of psychotic-like symptoms, and 
auditory stimuli detection threshold. Behavioral data from the fMRI task was analyzed using 
custom Matlab scripts provided by Powers and colleagues (2017). An unpaired two-sample t-test 
examined between-group differences in detection threshold (db SNR), in the probability of 
participants responding “yes” at each detection likelihood (no stimuli present, 25%, 50%, and 
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75%). An analysis of variance (ANOVA) was run to determine whether there was a significant 
between-group difference in participants’ confidence when responding ‘yes’ or ‘no’ at each 
detection likelihood during test trials.  
fMRI Data Analysis 
 
Preprocessing and functional analysis was conducted using AFNI (Cox, 1996) and FSL 
(FMRIB Software Library). Functional runs from each subject were corrected for slice 
acquisition time, realigned to the middle volume of the series, spatially smoothed with a 
Gaussian kernel (6 mm FWHM) and the time series was high-pass filtered using Gaussian-
weighted least-squares (max= 1/128 Hz). Functional data were linearly aligned to Montreal 
Neurological Institute (MNI) space. All four task runs were combined into a single run, the first 
6 TRs were removed from both imaging data and stimulus timing files. Single subject data were 
analyzed using a fixed effects model with task modeled as a canonical hemodynamic response. 
For the purpose of analysis, trials were split by response type (“yes” or “no”) and stimulus 
intensity (likelihood detection). Contrasts included each response type and detection likelihood 
(“0Yes,” “0No,” “25Yes,” “25No,” “50Yes,” “50No”, “75Yes”, and “75No”), and difference in 
responding yes versus no to no-tone (“0Yes” – “0No”). For whole brain analysis, statistical maps 
used a threshold of p < .01 and one-sided (NN=3) cluster significance of p < .05. The lowest 
FDR q-value was 0.9. A region-of-interest (ROI) analysis was conducted for bilateral anterior 
cingulate cortex (ACC) and paracentral lobule (PCL) (four regions total). An ROI mask was 
created by resampling the statistical dataset to ensure same resolution and boundaries across 
subjects and group. Beta weights were extracted for each region and each contrast.  
MRS Data Analysis 
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MRS data were analyzed using the FID-A (Simpson, Devenyi, Jezzard, Hennessy, & 
Near, 2017) toolkit in MATLAB, custom python scripts, FSL (Oxford University, Oxford, UK), 
and Tarquin (Wilson, Reynolds, Kauppinen, Arvanitis, & Peet, 2011) to fit the spectra. Custom 
python scripts were used to parse the MRS DICOM files, create a VOI mask for each region, and 
merge each of the runs (three runs each for PRESS and MEGA-PRESS sequences). Using the 
FID-A toolkit, all spectra were phase aligned with reference to water, bad averages were 
removed, corrected for frequency drift and phase drift, zero filled from 1024 to 4096, apodized 
with a 4 Hz Gaussian filter, and frequency aligned. Initially, spectra were frequency aligned to 
N-acetylaspartate (NAA) at 2.02 ppm, however due to the instability of NAA as a reference, 
spectra were separately aligned to creatine (Cr) at 3.02 ppm. Normalizing to creatine reduces 
intersubject variance attributable to differences in global signal strength and has been shown to 
yield reliable GABA concentration estimates (Bogner et al., 2009). Peak integration was used to 
quantify total concentrations of each metabolite. The final spectra were visually examined for 
artifact and quality of the fit. For each subject, FSL was used to segment tissue volume in order 
to derive CSF and white matter volumes which were applied to each VOI and used as control 
variables in all statistical analyses.  
The ratio of total Glu/total creatine and GABA/total creatine was used for hypothesis 
testing. Statistical testing was also conducted using NAA as the denominator in the ratio. For 
each statistical test, were entered as control variables. All statistical analysis of group differences 










Characteristics of Study Subjects  
 
There was no significant between-group difference in age (t (13) = 0.26, p= 0.80), gender 
(c2 (1, N=16)= 0.00, p = 1.00), ethnicity, (c2 (1, N=16)= 3.89, p= 0.14, sexual orientation (c2 (1, 
N=16)= 0.07, p= 0.79), or number of years of education (t (14)= 0.24, p= 0.82) (Table 1). There 
was also no between-group difference in full-scale IQ (FSIQ) (t (13) = 1.40, p= 0.19). These 
demographic variables also did not differ significantly between group when only including those 
participants that completed all procedures.   
Participants completed several self-report measures that assessed their propensity to 
experience perceptual abnormalities and delusional beliefs. There was a significant between-
group difference in total scores on the Launay-Slade Hallucination Scale, (t (14) = -5.42, p < 
0.001), which has previously been shown specificity for experiencing auditory hallucinations 
(Aleman et al., 2001; Levitan et al., 1996; Waters et al., 2003). There were no between-group 
differences on other measures of psychotic-like experiences including perceptual aberrations 
(Chapman Total Sore, t (14) = -0.28, p= 0.78), schizotypal traits (SPQ Total Score, t (14) = -
1.37, p= 0.19), and delusional beliefs (PDI Total Score, t (14) = -1.59, p= 0.14) (Table 2). There 
were also no significant between-group differences on subscales of the SPQ that have previously 
been associated with perceptual abnormalities and schizotypal traits such as the 
cognitive/perpetual subscale (t (14) = -0.95, p= 0.36), and perceptual abnormalities subscale (t 
(14) = -1.78, p= 0.10). Across several different measures of schizotypal traits and susceptibility 
to experience perceptual aberrations, the only significant group difference emerged in total 
LSHS-R scores.  
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In addition to IQ testing, participants that screened into Phase B of the study completed 
tests of working memory and processing speed that have been previously demonstrated to differ 
between healthy individual and those with psychosis (Cornelis et al., 2014; Murtagh et al., 2010) 
as well as those at-risk for psychosis (Addington, Liu, et al., 2017; Paolo Fusar-Poli et al., 2012). 
There was also no between-group difference in processing speed as measured by differences in 
the average T-score on the Digit Symbol Substitution Test (DSST), (t (14) = 1.35, p= 0.20).  
There was also significant between-group difference in working memory abilities as measured 
by group differences in average T-score on the Letter Number Sequencing test (LNS), (t (14) = 
1.51, p= 0.15).  
Task Performance   
There was no significant difference in the detection threshold between groups ((t (12) = 
1.41, p= 0.18), indicating that differences in task performance were not likely driven by 
individual or group differences in the decibel level of the target audio stimuli (Figure 3A). 
Participants in the STP+ group were significantly more likely to response “yes” during the no-
tone condition (t (12)= -2.30 ,  p < .05), however there was no significant differences in the 
probability of endorsing a response at the 25% ((t (12) = -1.03, p= 0.32 ), 50% ( (t (12) = -0.04, 
p= 0.92), or 75% ((t (12) = -0.06, p= 0.94 ) detection threshold (Figure 3B).  Across all 
participants, the probability of responding “yes” when there was no tone positively correlated 
with self-reported hallucination severity as measured by LSHS-R total scores (R^2= 0.31, p < 
.001) (Figure 3C). Overall these results are consistent with previous findings that voice-hearers 
without a psychosis diagnosis are more likely to endorse conditioned hallucinations (A R Powers 
et al., 2017), and this effect is not accounted for by group differences in auditory detection 
thresholding. It is also consistent with previous findings of a strong positive linear relation 
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between hallucination severity, as measured by LSHS-R total score, and the probability of 
endorsing conditioned hallucinations.  
In addition to responding whether or not the tone was detected, participants rated their 
level of confidence in their answer during each test trial. Participants rated their confidence 
similarly across most conditions. There was no group-by-condition difference in confidence 
ratings at the 25% (F (3, 22) = 0.68, p = 0.58), 50% (F (3, 22) = 0.11, p = 0.96), or 75% (F (3, 
22) = 3.36, p = 0.07) detection threshold (Figure 3C). However, there was a significant between-
group difference in confidence ratings in the no-tone (0% detection) condition (F (3, 22) = 3.93, 
p =.05), which was driven by a higher confidence in “yes” responses to the no-tone condition in 
the STP+ group compared to the STP- group (t (14) = -3.36, p < .01)).  This provides further 
support for the higher likelihood of endorsing false percepts in the STP+ group being driven by a 
strong belief in the association of the conditioned stimuli, rather than less confidence in their 
predictions. Yet there was no significant correlation between hallucination severity and the 
confidence with which conditioned hallucination were reported (R2= 0.08, p = 0.32). It is likely 
that the high variability in confidence ratings in the STP+ group, and low samples size, 
decreased the ability to detect and association between confidence ratings and hallucination 
severity.  
fMRI Results   
Whole-brain fMRI analysis revealed few clusters that survived statistical correction. 
Cluster-based correction revealed small regions of activation across several contrasts (k < 20). 
When responding “yes” to no-tone trials (endorsing conditioned hallucinations), the STP+ group 
demonstrated higher activation than the STP- group in several regions previously associated with 
the neurobiology of hallucinations (Figure 4) including the cerebellum (k= 6, Z= 3.12, peak at 
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20, 31, -45), right middle frontal gyrus (k= 4, Z= 3.19, peak at 25, -52, 3), superior temporal 
gyrus (k= 3, Z= 3.13, peak at -43, 6, -15), thalamus (k= 3, Z= 3.12, peak at 20, 31, -45), right 
insula (k= 3, Z= 3.12, peak at 20, 31, -45), and right middle cingulate cortex (k= 3, Z= 3.12, peak 
at 20, 31, -45). However, there were also clusters in regions that have not been associated with 
auditory verbal hallucinations including the brain stem (k= 5, Z= 3.56, peak at 8, 26, -30) and 
right cerebellum white matter (k= 3, Z= 3.29, peak at 28, 46, -47). Although these results provide 
some evidence that conditioned hallucinations activate the same regions consistent with previous 
studies (Zmigrod et al., 2016) on the neurobiology of hallucinations in psychotic disorders, and 
that activation patterns appear to differ between groups, these results should be interpreted 
cautiously given the sample size, number and size of clusters that survived statistical correction, 
and relatively large q value (0.5).   
When subtracting “no” responses from “yes” responses during no-tone trials, the STP+ 
group demonstrated higher levels of activation in several regions hypothesized to be involved in 
the neurobiology associated with the overweighting of top down priors including the left inferior 
frontal gyrus (k= 18, Z= 3.21, peak at -53, -35, -5), left middle temporal gyrus (k= 15, Z= 3.28, 
peak at -55, 26, -2) and right caudate (k= 6, Z= 3.18, peak at 13, -22, -11). The majority of the 
clusters that reached statistical significance were also notably small in size (Figure 4B). While 
providing some consistent evidence of overlap in the neurobiology of conditioned hallucinators 
with hallucinations in psychotic disorders, these results should be interpreted conservatively 
given the above-noted limitations of the sample size, cluster-based correction, and whole-brain 
exploratory fMRI analysis approach.  
Given this study’s a prior hypothesis on the role of ACC glutamate and GABA 
dysfunction in the neurobiology of conditioned hallucinations, a region-of-interest (ROI) fMRI 
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analysis was conducted for the bilateral ACC and control region (PCL). During conditioned 
hallucinations, hallucinators exhibited higher levels of activation in several voxels with the right 
ACC (B= 0.57, q= 0.05, p = 0.001) but not the left ACC (Figure 5A). There were also significant 
between-group activation differences within the right PCL (B= 0.47, q= 0.05, p = 0.001), 
contrary to stated hypotheses (Figure 5B). Similar unilateral patterns of activation differences 
emerged in the right ACC (B= 0.45, q= 0.05, p = 0.003) (Figure 5C) and right PCL (B= 0.18, q= 
0.05, p = 0.003) (Figure 5D) when subtracting “no” responses from “yes” responses to no-tone 
trials. The magnitude of these activation differences was notably smaller compared to the 
conditioned hallucinations contrast. There were no between-group differences in the left ACC or 
left PCL for either contrast. ROI analysis of the ACC during correct rejections (“no” responses to 
no-tone trials) demonstrated lower levels of activation in the STP+ group compared to the STP- 
group (not shown), consistent with previous findings (Powers et al., 2017). Given increases in 
activation of frontal regions during conditioned hallucinations, consistent with the hypothesis of 
overweighting top-down priors, this finding suggests that hallucinators exert less cognitive 
control during correct rejections, perhaps due to difficulties with stimulus detection (Wang, 
Ulbert, Schomer, Marinkovic, & Halgren, 2005). 
MRS Results   
 A multiple linear regression model was used to examine between group differences in the 
ratio of Glu/Cr and GABA/Cr in the ACC compared to the control region, and to examine 
between-group differences in cortical excitability (Glu/GABA ratio). For all linear models, 
individual differences in the percent of cerebral spinal fluid and percent of white matter were 
entered as control variables. While there was no significant group x region interaction in the ratio 
of glutamate to creatine, F (2,25) = 1.83, p= 0.18, there was a significant between-group 
difference in glutamate concentration in the anterior cingulate cortex, F (1,13) = 4.57, p= 0.05, 
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but no such difference in the control region, F (1,11) = 0.77, p= 0.40, (Figure 6A). The finding of 
higher levels of ACC Glu/Cr ratio is consistent with predictions and previous MRS studies of 
individuals with psychosis (Marsman et al., 2013). The inability to detect a group x region 
interaction may have been driven by low variability in PCL Glu/Cr concentrations in the minus 
group coupled with high variability in Glu/Cr concentrations in the plus group.  
Consistent with hypothesized predictions, there was a statistically significant group x 
region interaction in GABA/Cr concentrations, F (2,25) = 15.86, p< 0.0001. Yet, contrary to 
predictions, this difference was driven by a larger GABA/Cr ratio in the plus group compared to 
the minus group in the PCL, F (1,11) =4.40, p= 0.05, (Figure 6B). There was no between-group 
difference in GABA/Cr concentrations in the ACC, F (1,13) = 2.17, p= 0.16.  
 As glutamate and GABA respectively represent the major excitatory and inhibitory 
neurotransmitters in the central nervous system, the ratio of glutamate to GABA is a commonly 
utilized measure of cortical excitability (Ford, Nibbs, & Crewther, 2017). To investigate 
between-group differences in cortical excitability, the concentration of total glutamate extracted 
from the PRESS sequence was divided by total GABA concentrations extracted from the 
MEGA-PRESS sequence for each group and each region. Overall there was a significant group x 
region interaction in cortical excitability levels, F (2,25) = 5.76, p< 0.01 (Figure 6C). Yet there 
was no between-group difference in excitability levels in the ACC, F (1,13) = 1.69, p= 0.22, or 
PCL, F (1,11) = 1.40, p= 0.26. This finding provides preliminary support, consistent with 
previous findings in psychosis (Overbeek et al., 2019), for the role of reduced cortical 




Discussion    
The present study aimed to investigate the neurobiology of conditioned hallucinations in 
a healthy undergraduate sample that differed in their propensity to endorse perceptual 
abnormalities. Overlap in the neural underpinnings of PA in those at risk for psychosis with 
hallucinations in psychotic illness may provide important insight into the spectrum of psychotic 
experiences and the pathogenesis that contributes to increased risk for conversion. Consistent 
with previous research (Powers et al., 2017), hallucinators were more likely to endorse 
conditioned hallucinations, and were more confident in their responses. Their responses were 
positively correlated with a measure of hallucinatory experiences, and were not due to between-
group differences in detection thresholding. These results provide further support for the 
predictive coding account of hallucinations and the role of expectation, prior learning, and 
perceptual knowledge in the etiology of perceptual abnormalities. It demonstrates that 
hallucinations can be reliably conditioned not only in those with a psychotic illness or 
personality disorder but also along the continuum of healthy individuals who differed in their 
propensity for experiencing perceptual aberrations.  
 Although there was a significant between-group difference in LSHS-R total scores, the 
two groups did not differ on several measures of schizotypal traits as measured by the SPQ, nor 
did they differ in mean total scores on the Peters et al. Delusions Inventory or the Chapman 
Perceptual Aberrations Scale. This may be explained in part by the fully dimensional aspect of 
the LSHS-R, which assumes that hallucinations exist on a continuum within the normal 
population (Aleman et al., 2001), compared to the quasi-dimensional approach of the Chapman, 
which implies that the experience of perceptual abnormalities outside of psychosis represents an 
at-risk state (Peters et al., 1995) or a slight variant of psychopathology.  While the factor 
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structure of the SPQ is fully dimensional in nature, the LSHS-R may be better suited to capture 
the specific construct of auditory perceptual abnormalities, whereas there is significant overlap in 
the constructs measured across various factors of the SPQ. Although the distribution of scores on 
these measures in the prescreening sample was consistent with previously-reported normative 
data, the small sample size and large standard deviations of total scores for those included in 
scanning procedures suggest the benefit of examining these issues further in a larger sample. 
These findings suggest that the present sample may more closely reflect PA in a healthy young-
adult population and may be less representative of an at-risk undergraduate sample. This may be 
especially helpful for understanding the experience of those who report daily auditory percepts 
without the associated distress associated with psychotic illness (Pinheiro et al., 2018; Powers et 
al., 2017).   
 Contrary to hypothesized predictions, there were no between-group differences in FSIQ, 
in processing speed, as measured by performance on the Digit-Symbol Substitution Task, or in 
working memory abilities, as measured by performance on the Letter-Number Sequencing task. 
These findings are consistent with the previously-noted observation of the current sample 
perhaps more closely approximating a healthy normative population rather than an at-risk 
sample. Yet even in help-seeking CHR individuals, there are inconsistent findings on when 
cognitive deficits emerge, their association with conversion likelihood, and the role of baseline 
measures in predicting long-term functional outcomes (Bora et al., 2014; Emre Bora & Murray, 
2014; Brewer et al., 2006). The most consistent predictive models of conversion risk (Addington, 
Liu, et al., 2017) include several factors not examined explicitly in the present study including 
baseline social functioning, bizarre thought content, and disordered communication. Several 
other studies have also reported no between-group differences in processing speed for both CHR 
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(Paolo Fusar-Poli et al., 2012) and psychosis samples (Cornelis et al., 2014). The present study 
also did not measure deficits in social cognition, which some (Piskulic et al., 2016; Shakeel et 
al., 2019) have noted are more consistent and persistently impaired in CHR individuals over the 
entire course of the prodromal period.  
fMRI results, which should be interpreted cautiously, were also consistent with previous 
findings on the neurobiology of conditioned hallucinations (Powers et al., 2017). Hallucinators 
demonstrated decreased activation in the ACC during correct rejections and increased activation 
during conditioned hallucinations. Decreased ACC engagement during correct rejections 
suggests that even when not experiencing aberrant percepts, hallucinators struggled with accurate 
reality monitoring (Wang et al., 2005), perhaps driven the overweighting of top-down prior 
perceptual learning. ACC activation has also been associated with perceptual learning related to 
conflict monitoring (Yeung & Nieuwenhuis, 2009), which is negatively correlated with error 
likelihood. Lower ACC activation patterns are associated with high levels of conflict and higher 
cognitive demand in decision-making tasks. This provides additional support for the ACC’s 
involvement in the weighting of prediction error during perceptual learning. The ACC is also 
critical for cognitive control (Barber & Carter, 2005; Lesh, Niendam, Minzenberg, & Carter, 
2011) and the inhibition of prepotent responses, suggesting that lower activation in hallucinators 
may indicate less inhibitory control. Notably, group differences in activation were not observed 
at other detection threshold levels. Collectively, these findings tentatively provide preliminary 
support for the overweighting of top-down priors in conditioned hallucinations. While whole-
brain analysis demonstrated activation in regions previously reported in symptom-capture fMRI 
studies of AVH (Zmigrod et al., 2016) and conditioned hallucinations (Powers et al., 2017), the 
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small sample size limited statistical correction, resulting small cluster sizes and small effect 
sizes. A larger sample is required to fully interpret these initial results.  
There was a higher ratio of glutamate to creatine in the STP+ group compared to the 
STP- group in the ACC, consistent with hypothesized predictions.  These differences were not 
observed in a control region, providing preliminary support for altered glutamatergic functioning 
in the neurobiology of conditioned hallucinations. This finding is consistent with previous meta-
analyses of MRS studies (Marsman et al., 2013; Merritt, Egerton, Kempton, Taylor, & McGuire, 
2016; Poels et al., 2014). The current results are not confounded by methodological factors that 
have likely contributed to mixed findings across previous MRS studies, such as the impact of 
medications, (none of the participants reported current psychotropic medication use), or 
differences in the percent of white matter and CSF across participants. The PRESS sequencing 
technique used in the present study has strong reliability (Baeshen et al., 2019; Yahya et al., 
2008) and utilized a well-established preprocessing pipeline (Simpson et al., 2017). Altered 
glutamatergic signaling in prefrontal regions including the ACC has been tied to hallucinations 
and psychotic symptoms more broadly across CHR, first-episode, and chronic samples. This is 
the first study to demonstrate NMDA-R hypofunction in conditioned hallucinations, suggesting 
strong overlap in the neurobiology of perceptual abnormalities and providing support for a 
dimensional approach in linking neurobiology to clinical phenomenology.  
While there was a significant group by region interaction in ratio of GABA to total 
creatine, this was driven by between-group differences in the control region with no group 
differences in the ACC. Similarly, a significant group by region difference in cortical excitability 
was not associated with between-group differences in the ACC. This may have been driven by 
the higher variability of GABA/Cr concentrations within both groups, combined with a lower 
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sample due to several participants not being able to complete full MRS scanning procedures. 
Meta-analyses of GABA levels in frontal regions have reported mixed results, with one study 
finding no differences between psychosis patients (Egerton et al., 2017) and healthy controls and 
a more recent, larger study reporting reduced GABA levels in the ACC of patients with 
psychosis (Kumar et al., 2020). Null findings in GABA concentration differences have also been 
reported in those at ultra-high risk for psychosis (Modinos et al., 2018). While cortical 
excitability has been associated with schizotypal traits (Ford et al., 2017) and cognitive abilities 
in first-episode patients (Overbeek et al., 2019), the current sample did not differ on any SPQ 
factors or total scores, nor did they differ in cognitive abilities. It is likely that the role of altered 
GABAergic functioning in psychotic experiences may be most relevant for understanding 
systems-level dysfunction and the interaction of frontal regions with other regions putative to 
pathogenesis of psychosis, including subcortical and temporal cortical regions(de Jonge et al., 
2017; McCutcheon et al., 2020). A longitudinal study (Modinos et al., 2018) following CHR 
individuals over the course of three years report baseline differences in the correlation of 
prefrontal GABA levels with regional cerebral blood flow in the hippocampus. Importantly, this 
association predicted conversion to psychosis. Future studies with multi-site samples may benefit 
from measuring GABA concentrations both within and across networks associated with NMDA 
hypofunction.  
 The current study has several important limitations.  Although both behavioral and 
neuroimaging results are consistent with results from Powers and colleagues (2017), the small 
sample size and large within-group variability suggest a highly cautious interpretation. It is likely 
that the current sample reflects the healthier end of the psychosis spectrum and therefore may not 
be generalizable to help-seeking at-risk clinical samples. Although the two groups differed in 
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their LSHS-R scores, this is unsurprising given that the measure was used to categorize 
participants as being high or low in their experience of perceptual abnormalities. It will be 
important for future studies of non-help-seeking young adult samples to reproduce the reliability 
of the LSHS-R in measuring hallucinations through administration of similar measures with 
strong psychometric properties. The PCL was chosen as a control region during MRS procedures 
as it is not implicated in the neurobiology of conditioned hallucinations, nor is it consistently 
activated in fMRI studies of auditory hallucinations. However, some studies report increased 
PCL activation in patients with auditory verbal hallucinations, and the region may be involved in 
critical for predictive coding. In addition to behavioral and neuroimaging results, computational 
modeling using a hierarchical gaussian filter approach is required to confirm whether confidence 
in reporting conditioned hallucinators is associated with the overweighting of top-down prior 
beliefs, consistent with predictive coding theory of hallucinations. Although some studies 
(Mathalon et al., 2019) suggest a low precision of priors of in the etiology of auditory verbal 
hallucinations, this may be specifically relate to the auditory system’s strong bias for speech and 
differential disruption of priors at different hierarchical levels from lower sensory cortices to 
higher-level order associative cortices (Sterzer et al., 2018). MRS measures both inactive and 
active metabolite concentrations, and the majority of physiologically active glutamate is derived 
from glutamine (Rowland et al., 2013). Future studies should also examine between-group 
differences in glutamine to determine whether Glu/Cr differences may be biased by measurement 
of extracellular inactive glutamate.   
 The current study aimed to build upon previous investigations of the predictive coding 
account of hallucinations by examining conditioned hallucinations in healthy, college-aged 
individuals who differ in their propensity toward endorsing perceptual aberrations and linking 
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the phenomenology of these experiences with the well-established role of prefrontal NMDA 
hypofunction in the neurobiology of hallucinations. STP+ individuals were more likely to 
endorse conditioned hallucinations and were more confident in their responses, which was 
associated with differences in ACC activation and Glu/Cr concentrations, but not GABA/Cr 
concentrations nor differences in cortical excitability. Consistent with previous findings of 
conditioned hallucinations (Powers et al., 2017) and predictive coding accounts of psychosis 
(Horga et al., 2014; Ranson et al., 2019; Sterzer et al., 2018; Teufel et al., 2015), these results 
require replication in a larger sample and application of computational techniques to determine 
whether these effects are driven by the overweighting of top-down prior beliefs. This is the first 
study to replicate the conditioned hallucination effect within the “healthy end” of the psychosis 
continuum, and the first study limited to college-aged individuals, a population that is important 
for broad-based screening efforts in the early detection and prevention of psychotic illnesses. 
While narrow in scope and limited in generalizability, the current study extends previous efforts 
(Corlett et al., 2009; Kapur, 2003) to conceptualize the phenomenology of hallucinations and its 
underlying neurobiology within a cognitive, computational framework. Continued efforts in this 
direction will be critical for not only further characterizing these symptoms, but also for 
developing new treatment modalities and biological targets that can improve the lives of those 




































Figure 1. PRISMA Diagram of Participant Recruitment.  
All Survey Participants (N= 552) 
Eligible (n=242) 
Screened for Phase 2 
(n=13) 
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(n=10) 
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Demographic  STP + Group STP – Group p value  
(Chi-Square or T-test) 
N 6 10 -- 
Age (years) 20.14 (0.60) 20.82 (2.45) 0.80 
Sex (% Female) 66.66% 70.00% 1.00 





Sexual Orientation 83.3% Heterosexual 90% Heterosexual 0.79 
Years of Education  13.5 (0.9) 13.1 (1.3) 0.82 
FSIQ, Mean (SD) 100 (10) 108 (11) 0.19 
 
Table 1. Phase B Participant Demographics. N= number of participants, FSIQ= Full-Scale Intelligence Quotient. P value represents 
results of either Chi-Square or independent samples t-test.  
 
Survey Measure  STP + Group (N=6) STP – Group (N=10) p value  
Total LSHS-R Score 29.00 (6.87) 9.10 (7.23) < 0.001 
Total PDI Score 54.83 (24.20) 37.75 (16.18) 0.14 
Total SPQ Score 28.17 (15.83) 17.10 (14.26) 0.19 
SPQ Perceptual Aberrations  2.83 (2.64) 1.10 (1.29) 0.10 
SPQ Cognitive Perceptual 10.17 (7.17)  7.00 (6.00) 0.36 
Chapman Total Score 7.83 (6.74) 7.00 (4.99) 0.78 
DSST T-Score 53.83 (5.95) 58.10 (6.21) 0.20 
LNS T-Score  49.33 (3.33) 56.40 (10.99) 0.15 
Table 2.  Phase B Self-Report and Cognitive Testing Results.  
LSHS-R= Launay-Slade Hallucination Scale Revised; PDI= Peters Delusion Inventory;  
SPQ= Schizotypal Personality Questionnaire; Chapman = Chapman Perceptual Aberration Scale;  







Figure 2: Participant Pool Survey Results. Violin Plot comparison of all eligible participants total scores on the Cognitive-Perceptual 
factor (CP) of the Schizotypal Personality Questionnaire (SPQ) and the Chapman Perceptual Aberration Scale. Red line indicates the 
mean SPQ- CP total score in patients with psychosis while the blue line represents SPQ-CP mean in healthy individuals (Raine, 1991). 
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Figure 3. Task Behavioral Data. There was no significant between-group difference in the detection threshold (dBSNR) levels (3A). 
The two groups differed in the probability of responding yes when no tone was presented, but there were no such differences in the 
probability of responding yes at the 25%, 50%, or 75% of the detection threshold (3B). The probability of responding yes to no tone 
correlated significantly with the LSHS-R total score (3C). The two groups differed in the level of confidence in “yes” versus “no” 
responses during the no tone condition, but this difference was not apparent at any other detection threshold level (3D). n.s.= not 
significant; * = p < 0.05; **= p < 0.01; ***= p < 0.001.  
 





Figure 4: Whole-Brain fMRI Results by Condition. Whole-brain analysis was conducted to determine activation during conditioned 
hallucinations. Cluster-based correction was utilized with a height threshold of p<.001 and cluster threshold of p<.05. Few clusters 
survived correction and all were small (k < 20) in size. Results shown for when participants responded “yes” to no-tone trials 
(conditioned hallucinations, 4A) and for differences between responding “yes” versus “no” to no-tone trials (4B). Tables indicates size 













Figure 5: Region of Interest (ROI) fMRI Results by Condition. ROI analysis was conducted to determine activation in the main region 
of interest of the study, the anterior cingulate (ACC), as well as in the control region, the paracentral lobule (PCL) during the 
conditioned hallucinations task. In the right ACC (x= -8, y=-32, z=6) there were several regions that demonstrated higher levels of 
activation during “yes” responses to no-tone trials (5A). There was also some activation in the right PCL (x= -7, y=-32, z=53) during 
this condition (5B). There was also increased activation when comparing “yes” responses to “no” responses in both the right ACC 











Figure 6. Magnetic Resonance Spectroscopy Results. Concentrations of total glutamate (ppm) as a ratio to total creatine 
concentrations (ppm) were higher in the anterior cingulate cortex (ACC) voxel for the STP Plus (plus) group compared to the STP 
Minus (minus) group but there was no between-group difference in the paracentral lobule (PCL) control voxel (6A). There was a 
significant group x region interaction in the concentrations of total GABA (ppm) as a percent of total creatine (ppm) concentration 
driven by a larger GABA/Cr ration in the plus group than the minus group in the control region (6B). There was a significant group by 
region interaction in cortical excitability as measured by the ratio of glutamate to GABA in the two regions (6C). n.s.= not significant; 




Adams, R. A., Stephan, K. E., Brown, H. R., Frith, C. D., & Friston, K. J. (2013). The 
computational anatomy of psychosis. Frontiers in Psychiatry, 4, 47. 
https://doi.org/10.3389/fpsyt.2013.00047 
Addington, J., Addington, D., Abidi, S., Raedler, T., & Remington, G. (2017). Canadian 
treatment guidelines for individuals at clinical high risk of psychosis. Canadian Journal 
of Psychiatry, 62(9), 656–661. https://doi.org/10.1177/0706743717719895 
Addington, J., Cadenhead, K. S., Cannon, T. D., Cornblatt, B., McGlashan, T. H., Perkins, D. O., 
… North American Prodrome Longitudinal Study. (2007). North American Prodrome 
Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia 
research. Schizophrenia Bulletin, 33(3), 665–672. https://doi.org/10.1093/schbul/sbl075 
Addington, J., Cadenhead, K. S., Cornblatt, B. A., Mathalon, D. H., McGlashan, T. H., Perkins, 
D. O., … Cannon, T. D. (2012). North American Prodrome Longitudinal Study (NAPLS 
2): overview and recruitment. Schizophrenia Research, 142(1–3), 77–82. 
https://doi.org/10.1016/j.schres.2012.09.012 
Addington, J., Liu, L., Buchy, L., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., … 
McGlashan, T. H. (2015). North american prodrome longitudinal study (NAPLS 2): the 
prodromal symptoms. The Journal of Nervous and Mental Disease, 203(5), 328–335. 
https://doi.org/10.1097/NMD.0000000000000290 
Addington, J., Liu, L., Perkins, D. O., Carrion, R. E., Keefe, R. S. E., & Woods, S. W. (2017). 
The role of cognition and social functioning as predictors in the transition to psychosis 
for youth with attenuated psychotic symptoms. Schizophrenia Bulletin, 43(1), 57–63. 
https://doi.org/10.1093/schbul/sbw152 
Addington, J., Stowkowy, J., Liu, L., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., … 
Woods, S. W. (2019). Clinical and functional characteristics of youth at clinical high-risk 
for psychosis who do not transition to psychosis. Psychological Medicine, 49(10), 1670–
1677. https://doi.org/10.1017/S0033291718002258 
Aleman, A., Nieuwenstein, M. R., Böcker, K. B. E., & De Haan, E. H. F. (2001). Multi-
dimensionality of hallucinatory predisposition: factor structure of the Launay–Slade 
Hallucination Scale in a normal sample. Personality and Individual Differences, 30(2), 
287–292. https://doi.org/10.1016/S0191-8869(00)00045-3 
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition (DSM-5). Retrieved February 22, 2020, from 
https://doi.org/10.1176/appi.books.9780890425596 
Anandakumar, T., Connaughton, E., Coltheart, M., & Langdon, R. (2017). Belief-bias reasoning 
in non-clinical delusion-prone individuals. Journal of Behavior Therapy and 
Experimental Psychiatry, 56, 71–78. https://doi.org/10.1016/j.jbtep.2017.02.005 
Axelrod, S. R., Grilo, C. M., Sanislow, C., & McGlashan, T. H. (2001). Schizotypal Personality 
Questionnaire-Brief: factor structure and convergent validity in inpatient adolescents. 
Journal of Personality Disorders, 15(2), 168–179. 
https://doi.org/10.1521/pedi.15.2.168.19219 
Baeshen, A., Wyss, P. O., Henning, A., O’Gorman, R. L., Piccirelli, M., Kollias, S., & Michels, 
L. (2019). Test-Retest Reliability of the Brain Metabolites GABA and Glx With JPRESS, 
PRESS, and MEGA-PRESS MRS Sequences in vivo at 3T. Journal of Magnetic 
Resonance Imaging. https://doi.org/10.1002/jmri.26921 
 49 
Barber, A. D., & Carter, C. S. (2005). Cognitive control involved in overcoming prepotent 
response tendencies and switching between tasks. Cerebral Cortex, 15(7), 899–912. 
https://doi.org/10.1093/cercor/bhh189 
Barch, D. (2017). 7. the neural mechanisms of cognitive control in psychosis. Schizophrenia 
Bulletin, 43(suppl_1), S9–S9. https://doi.org/10.1093/schbul/sbx021.026 
Barkus, E., Stirling, J., French, P., Morrison, A., Bentall, R., & Lewis, S. (2010). Distress and 
metacognition in psychosis prone individuals: comparing high schizotypy to the at-risk 
mental state. The Journal of Nervous and Mental Disease, 198(2), 99–104. 
https://doi.org/10.1097/NMD.0b013e3181cc418a 
Bentall, R. P., & Slade, P. D. (1985). Reliability of a scale measuring disposition towards 
hallucination: a brief report. Personality and Individual Differences, 6(4), 527–529. 
https://doi.org/10.1016/0191-8869(85)90151-5 
Bora, E, Lin, A., Wood, S. J., Yung, A. R., McGorry, P. D., & Pantelis, C. (2014). Cognitive 
deficits in youth with familial and clinical high risk to psychosis: a systematic review and 
meta-analysis. Acta Psychiatrica Scandinavica, 130(1), 1–15. 
https://doi.org/10.1111/acps.12261 
Bora, Emre, & Murray, R. M. (2014). Meta-analysis of cognitive deficits in ultra-high risk to 
psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the 
onset of psychosis? Schizophrenia Bulletin, 40(4), 744–755. 
https://doi.org/10.1093/schbul/sbt085 
Brewer, W. J., Wood, S. J., Phillips, L. J., Francey, S. M., Pantelis, C., Yung, A. R., … 
McGorry, P. D. (2006). Generalized and specific cognitive performance in clinical high-
risk cohorts: a review highlighting potential vulnerability markers for psychosis. 
Schizophrenia Bulletin, 32(3), 538–555. https://doi.org/10.1093/schbul/sbj077 
Callaway, D. A., Cohen, A. S., Matthews, R. A., & Dinzeo, T. (2014). Schizotypal Personality 
Questionnaire-Brief Revised: psychometric replication and extension. Personality 
Disorders : Theory, Research, and Treatment, 5(1), 32–38. 
https://doi.org/10.1037/per0000041 
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., … 
Heinssen, R. (2008). Prediction of psychosis in youth at high clinical risk: a multisite 
longitudinal study in North America. Archives of General Psychiatry, 65(1), 28–37. 
https://doi.org/10.1001/archgenpsychiatry.2007.3 
Chan, C. C., Bulbena-Cabre, A., Rutter, S., Benavides, C., McClure, M. M., Calabrese, W., … 
Mercedes Perez-Rodriguez, M. (2019). Comparison of self-report and clinician-rated 
schizotypal traits in schizotypal personality disorder and community controls. 
Schizophrenia Research, 209, 263–268. https://doi.org/10.1016/j.schres.2018.12.050 
Chan, R. C., Shi, H. S., Geng, F. L., Liu, W. H., Yan, C., Wang, Y., & Gooding, D. C. (2015). 
The Chapman psychosis-proneness scales: Consistency across culture and time. 
Psychiatry Research, 228(1), 143–149. https://doi.org/10.1016/j.psychres.2015.04.031 
Chapman, H. C., Visser, K. F., Mittal, V. A., Gibb, B. E., Coles, M. E., & Strauss, G. P. (2020). 
Emotion regulation across the psychosis continuum. Development and Psychopathology, 
32(1), 219–227. https://doi.org/10.1017/S0954579418001682 
Chapman, L. J., Chapman, J. P., Kwapil, T. R., Eckblad, M., & Zinser, M. C. (1994). Putatively 
psychosis-prone subjects 10 years later. Journal of Abnormal Psychology, 103(2), 171–
183. https://doi.org/10.1037//0021-843x.103.2.171 
Chapman, L. J., Chapman, J. P., & Raulin, M. L. (1978). Body-image aberration in 
 50 
Schizophrenia. Journal of Abnormal Psychology, 87(4), 399–407. 
https://doi.org/10.1037//0021-843x.87.4.399 
Chiappelli, F. (2018). Advances in psychobiology. (A. Witjenburg, Trans.). New York: Nova 
Biomedical. 
Cohen, R. A., & Sweet, L. H. (Eds.). (2011). Brain imaging in behavioral medicine and clinical 
neuroscience. New York, NY: Springer New York. https://doi.org/10.1007/978-1-4419-
6373-4 
Compton, M. T., Goulding, S. M., Bakeman, R., & McClure-Tone, E. B. (2009). Confirmation 
of a four-factor structure of the Schizotypal Personality Questionnaire among 
undergraduate students. Schizophrenia Research, 111(1–3), 46–52. 
https://doi.org/10.1016/j.schres.2009.02.012 
Cordon, I., Nicolás, M. J., Arrieta, S., Lopetegui, E., López-Azcárate, J., Alegre, M., … 
Valencia, M. (2015). Coupling in the cortico-basal ganglia circuit is aberrant in the 
ketamine model of schizophrenia. European Neuropsychopharmacology, 25(8), 1375–
1387. https://doi.org/10.1016/j.euroneuro.2015.04.004 
Corlett, P. R., Frith, C. D., & Fletcher, P. C. (2009). From drugs to deprivation: a Bayesian 
framework for understanding models of psychosis. Psychopharmacology, 206(4), 515–
530. https://doi.org/10.1007/s00213-009-1561-0 
Corlett, P. R., Taylor, J. R., Wang, X. J., Fletcher, P. C., & Krystal, J. H. (2010). Toward a 
neurobiology of delusions. Progress in Neurobiology, 92(3), 345–369. 
https://doi.org/10.1016/j.pneurobio.2010.06.007 
Cornelis, C., De Picker, L. J., Hulstijn, W., Dumont, G., Timmers, M., Janssens, L., … Morrens, 
M. (2014). Preserved Learning during the Symbol-Digit Substitution Test in Patients with 
Schizophrenia, Age-Matched Controls, and Elderly. Frontiers in Psychiatry, 5, 189. 
https://doi.org/10.3389/fpsyt.2014.00189 
Cox, R. W. (1996). AFNI: software for analysis and visualization of functional magnetic 
resonance neuroimages. Computers and Biomedical Research, an International Journal, 
29(3), 162–173. https://doi.org/10.1006/cbmr.1996.0014 
de Jonge, J. C., Vinkers, C. H., Hulshoff Pol, H. E., & Marsman, A. (2017). Gabaergic 
mechanisms in schizophrenia: linking postmortem and in vivo studies. Frontiers in 
Psychiatry, 8, 118. https://doi.org/10.3389/fpsyt.2017.00118 
Dhamala, E., Abdelkefi, I., Nguyen, M., Hennessy, T. J., Nadeau, H., & Near, J. (2019). 
Validation of in vivo MRS measures of metabolite concentrations in the human brain. 
NMR in Biomedicine, 32(3), e4058. https://doi.org/10.1002/nbm.4058 
Dumont, R., & Willis, J. O. (2008). Wechsler abbreviated scale of intelligence. In C. R. 
Reynolds & E. Fletcher-Janzen (Eds.), Encyclopedia of special education. Hoboken, NJ, 
USA: John Wiley & Sons, Inc. https://doi.org/10.1002/9780470373699.speced2202 
Egerton, A., Modinos, G., Ferrera, D., & McGuire, P. (2017). Neuroimaging studies of GABA in 
schizophrenia: a systematic review with meta-analysis. Translational Psychiatry, 7(6), 
e1147. https://doi.org/10.1038/tp.2017.124 
Faro, S. H., Mohamed, F. B., Law, M., & Ulmer, J. T. (Eds.). (2012). Functional 
neuroradiology: principles and clinical applications. Boston, MA: Springer US. 
https://doi.org/10.1007/978-1-4419-0345-7 
First, M. B. (2014). Structured Clinical Interview for the DSM (SCID). In R. L. Cautin & S. O. 
Lilienfeld (Eds.), The encyclopedia of clinical psychology (pp. 1–6). Hoboken, NJ, USA: 
John Wiley & Sons, Inc. https://doi.org/10.1002/9781118625392.wbecp351 
 51 
Fonseca-Pedrero, E., Cohen, A., Ortuño-Sierra, J., de Álbeniz, A. P., & Muñiz, J. (2017). 
Dimensional Structure and Measurement Invariance of the Schizotypal Personality 
Questionnaire - Brief Revised (SPQ-BR) Scores Across American and Spanish Samples. 
Journal of Personality Disorders, 31(4), 522–541. 
https://doi.org/10.1521/pedi_2016_30_266 
Fonseca-Pedrero, E., Paino, M., Santarén-Rosell, M., Lemos-Giráldez, S., & Muñiz, J. (2012). 
Psychometric properties of the Peters et al Delusions Inventory 21 in college students. 
Comprehensive Psychiatry, 53(6), 893–899. 
https://doi.org/10.1016/j.comppsych.2012.01.007 
Ford, T. C., Nibbs, R., & Crewther, D. P. (2017). Glutamate/GABA+ ratio is associated with the 
psychosocial domain of autistic and schizotypal traits. Plos One, 12(7), e0181961. 
https://doi.org/10.1371/journal.pone.0181961 
Fusar-Poli, P, Stone, J. M., Broome, M. R., Valli, I., Mechelli, A., McLean, M. A., … McGuire, 
P. K. (2011). Thalamic glutamate levels as a predictor of cortical response during 
executive functioning in subjects at high risk for psychosis. Archives of General 
Psychiatry, 68(9), 881–890. https://doi.org/10.1001/archgenpsychiatry.2011.46 
Fusar-Poli, Paolo, Bechdolf, A., Taylor, M. J., Bonoldi, I., Carpenter, W. T., Yung, A. R., & 
McGuire, P. (2013). At risk for schizophrenic or affective psychoses? A meta-analysis of 
DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophrenia 
Bulletin, 39(4), 923–932. https://doi.org/10.1093/schbul/sbs060 
Fusar-Poli, Paolo, Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-
Lutter, F., … Yung, A. (2013). The psychosis high-risk state: a comprehensive state-of-
the-art review. JAMA Psychiatry, 70(1), 107–120. 
https://doi.org/10.1001/jamapsychiatry.2013.269 
Fusar-Poli, Paolo, Deste, G., Smieskova, R., Barlati, S., Yung, A. R., Howes, O., … Borgwardt, 
S. (2012). Cognitive functioning in prodromal psychosis: A meta-analysis. JAMA 
Psychiatry, 69(6), 562–571. 
Garety, P. A., & Hemsley, D. R. (1987). Characteristics of delusional experience. European 
Archives of Psychiatry and Neurological Sciences, 236(5), 294–298. 
https://doi.org/10.1007/bf00380955 
Gold, J., Carpenter, C., Randolph, C., Goldberg, T., & Weinberger, D. (1995). Auditory working 
memory and the Wisconsin card sorting test. Schizophrenia Research, 15(1–2), 117–118. 
https://doi.org/10.1016/0920-9964(95)95361-C 
Goldberg, T. E., David, A., & Gold, J. M. (2003). Neurocognitive deficits in schizophrenia. In S. 
R. Hirsch & D. R. Weinberger (Eds.), Schizophrenia (pp. 168–184). Oxford, UK: 
Blackwell Science Ltd. https://doi.org/10.1002/9780470987353.ch10 
Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in 
schizophrenia? The American Journal of Psychiatry, 153(3), 321–330. 
https://doi.org/10.1176/ajp.153.3.321 
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and 
functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophrenia 
Bulletin, 26(1), 119–136. https://doi.org/10.1093/oxfordjournals.schbul.a033430 
Haut, M. W., Kuwabara, H., Leach, S., & Arias, R. G. (2000). Neural activation during 
performance of number-letter sequencing. Applied Neuropsychology, 7(4), 237–242. 
https://doi.org/10.1207/S15324826AN0704_5 
Hernández Lorca, M. (2018). Psychtoolbox. a brief guide to start programming experiments in 
 52 
psychology. UAM Ediciones. https://doi.org/10.15366/manual.psych2018 
Holdnack, J. A., Schoenberg, M. R., Lange, R. T., & Iverson, G. L. (2013). Predicting premorbid 
ability for WAIS–IV, WMS–IV and WASI–II. In WAIS-IV, WMS-IV, and ACS (pp. 217–
278). Elsevier. https://doi.org/10.1016/B978-0-12-386934-0.00005-5 
Horga, G., & Abi-Dargham, A. (2019). An integrative framework for perceptual disturbances in 
psychosis. Nature Reviews. Neuroscience, 20(12), 763–778. 
https://doi.org/10.1038/s41583-019-0234-1 
Horga, G., Schatz, K. C., Abi-Dargham, A., & Peterson, B. S. (2014). Deficits in predictive 
coding underlie hallucinations in schizophrenia. The Journal of Neuroscience, 34(24), 
8072–8082. https://doi.org/10.1523/JNEUROSCI.0200-14.2014 
Hurford, I. M., Marder, S. R., Keefe, R. S. E., Reise, S. P., & Bilder, R. M. (2011). A brief 
cognitive assessment tool for schizophrenia: construction of a tool for clinicians. 
Schizophrenia Bulletin, 37(3), 538–545. https://doi.org/10.1093/schbul/sbp095 
Kapur, S. (2003). Psychosis as a state of aberrant salience: a framework linking biology, 
phenomenology, and pharmacology in schizophrenia. The American Journal of 
Psychiatry, 160(1), 13–23. https://doi.org/10.1176/appi.ajp.160.1.13 
Kegeles, L. S., Mao, X., Stanford, A. D., Girgis, R., Ojeil, N., Xu, X., … Shungu, D. C. (2012). 
Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in 
schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Archives 
of General Psychiatry, 69(5), 449–459. 
https://doi.org/10.1001/archgenpsychiatry.2011.1519 
Keshavan, M. S., Dick, R. M., Diwadkar, V. A., Montrose, D. M., Prasad, K. M., & Stanley, J. 
A. (2009). Striatal metabolic alterations in non-psychotic adolescent offspring at risk for 
schizophrenia: a (1)H spectroscopy study. Schizophrenia Research, 115(1), 88–93. 
https://doi.org/10.1016/j.schres.2009.08.012 
Kim, S. H., Jung, H. Y., Hwang, S. S., Chang, J. S., Kim, Y., Ahn, Y. M., & Kim, Y. S. (2010). 
The usefulness of a self-report questionnaire measuring auditory verbal hallucinations. 
Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(6), 968–973. 
https://doi.org/10.1016/j.pnpbp.2010.05.005 
Kittelberger, K., Hur, E. E., Sazegar, S., Keshavan, V., & Kocsis, B. (2012). Comparison of the 
effects of acute and chronic administration of ketamine on hippocampal oscillations: 
relevance for the NMDA receptor hypofunction model of schizophrenia. Brain Structure 
& Function, 217(2), 395–409. https://doi.org/10.1007/s00429-011-0351-8 
Kleiner, M., Brainard, D. H., Pelli, D., Ingling, A., Murray, R., & Broussard, C. (2007). What’s 
new in Psychtoolbox-3. Perception, 36, 1–16. 
Kline, E., Thompson, E., Demro, C., Bussell, K., Reeves, G., & Schiffman, J. (2016). Self-
Report Instruments for Clinical Monitoring of Psychosis Risk States. Psychiatric 
Services, 67(4), 456–459. https://doi.org/10.1176/appi.ps.201500063 
Kline, E., Wilson, C., Ereshefsky, S., Denenny, D., Thompson, E., Pitts, S. C., … Schiffman, J. 
(2012). Psychosis risk screening in youth: a validation study of three self-report measures 
of attenuated psychosis symptoms. Schizophrenia Research, 141(1), 72–77. 
https://doi.org/10.1016/j.schres.2012.07.022 
Kokkinou, M., Ashok, A. H., & Howes, O. D. (2018). The effects of ketamine on dopaminergic 
function: meta-analysis and review of the implications for neuropsychiatric disorders. 
Molecular Psychiatry, 23(1), 59–69. https://doi.org/10.1038/mp.2017.190 
Kort, N. S., Ford, J. M., Roach, B. J., Gunduz-Bruce, H., Krystal, J. H., Jaeger, J., … Mathalon, 
 53 
D. H. (2017). Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive 
Coding Deficits in Schizophrenia. Biological Psychiatry, 81(6), 514–524. 
https://doi.org/10.1016/j.biopsych.2016.06.019 
Kråkvik, B., Larøi, F., Kalhovde, A. M., Hugdahl, K., Kompus, K., Salvesen, Ø., … Vedul-
Kjelsås, E. (2015). Prevalence of auditory verbal hallucinations in a general population: 
A group comparison study. Scandinavian Journal of Psychology, 56(5), 508–515. 
https://doi.org/10.1111/sjop.12236 
Kumar, V., Vajawat, B., & Rao, N. P. (2020). Frontal GABA in schizophrenia: a meta-analysis 
of 1H-MRS studies. The World Journal of Biological Psychiatry, 1–25. 
https://doi.org/10.1080/15622975.2020.1731925 
Launay, G., & Slade, P. (1981). The measurement of hallucinatory predisposition in male and 
female prisoners. Personality and Individual Differences, 2(3), 221–234. 
https://doi.org/10.1016/0191-8869(81)90027-1 
Lesh, T. A., Niendam, T. A., Minzenberg, M. J., & Carter, C. S. (2011). Cognitive control 
deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology, 36(1), 
316–338. https://doi.org/10.1038/npp.2010.156 
Levitan, C., Ward, P. B., Catts, S. V., & Hemsley, D. R. (1996). Predisposition toward auditory 
hallucinations: the utility of the Launay-Slade Hallucination Scale in psychiatric patients. 
Personality and Individual Differences, 21(2), 287–289. https://doi.org/10.1016/0191-
8869(96)00052-9 
Linscott, R. J., & van Os, J. (2013). An updated and conservative systematic review and meta-
analysis of epidemiological evidence on psychotic experiences in children and adults: on 
the pathway from proneness to persistence to dimensional expression across mental 
disorders. Psychological Medicine, 43(6), 1133–1149. 
https://doi.org/10.1017/S0033291712001626 
Løberg, E.-M., Gjestad, R., Posserud, M.-B., Kompus, K., & Lundervold, A. J. (2019). 
Psychosocial characteristics differentiate non-distressing and distressing voices in 10,346 
adolescents. European Child & Adolescent Psychiatry, 28(10), 1353–1363. 
https://doi.org/10.1007/s00787-019-01292-x 
Marshall, C., Lu, Y., Lyngberg, K., Deighton, S., Cadenhead, K. S., Cannon, T. D., … 
Addington, J. (2019). Changes in symptom content from a clinical high-risk state to 
conversion to psychosis. Early Intervention in Psychiatry, 13(2), 257–263. 
https://doi.org/10.1111/eip.12473 
Marsman, A., van den Heuvel, M. P., Klomp, D. W. J., Kahn, R. S., Luijten, P. R., & Hulshoff 
Pol, H. E. (2013). Glutamate in schizophrenia: a focused review and meta-analysis of 1H-
MRS studies. Schizophrenia Bulletin, 39(1), 120–129. 
https://doi.org/10.1093/schbul/sbr069 
Mathalon, D. H., Roach, B. J., Ferri, J. M., Loewy, R. L., Stuart, B. K., Perez, V. B., … Ford, J. 
M. (2019). Deficient auditory predictive coding during vocalization in the psychosis risk 
syndrome and in early illness schizophrenia: the final expanded sample. Psychological 
Medicine, 49(11), 1897–1904. https://doi.org/10.1017/S0033291718002659 
Mathys. (2017, March). Hierarchical Bayesian Modeling of Volatile Environments . Presented at 
the The Abdus Salam International Centre for Theoretical Physics, Trieste, Italy. 
Mathys, Lomakina, E. I., Daunizeau, J., Iglesias, S., Brodersen, K. H., Friston, K. J., & Stephan, 
K. E. (2014). Uncertainty in perception and the Hierarchical Gaussian Filter. Frontiers in 
Human Neuroscience, 8, 825. https://doi.org/10.3389/fnhum.2014.00825 
 54 
McCrimmon, A. W., & Smith, A. D. (2013). Review of the Wechsler Abbreviated Scale of 
Intelligence, Second Edition (WASI-II). Journal of Psychoeducational Assessment, 
31(3), 337–341. https://doi.org/10.1177/0734282912467756 
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020). Dopamine and glutamate in 
schizophrenia: biology, symptoms and treatment. World Psychiatry : Official Journal of 
the World Psychiatric Association (WPA), 19(1), 15–33. 
https://doi.org/10.1002/wps.20693 
Merritt, K., Egerton, A., Kempton, M. J., Taylor, M. J., & McGuire, P. K. (2016). Nature of 
Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance 
Spectroscopy Studies. JAMA Psychiatry, 73(7), 665–674. 
https://doi.org/10.1001/jamapsychiatry.2016.0442 
Michaels, T. I., Long, L. L., Stevenson, I. H., Chrobak, J. J., & Chen, C.-M. A. (2018). Effects of 
chronic ketamine on hippocampal cross-frequency coupling: implications for 
schizophrenia pathophysiology. The European Journal of Neuroscience, 48(8), 2903–
2914. https://doi.org/10.1111/ejn.13822 
Mikkelsen, M., Barker, P. B., Bhattacharyya, P. K., Brix, M. K., Buur, P. F., Cecil, K. M., … 
Edden, R. A. E. (2017). Big GABA: Edited MR spectroscopy at 24 research sites. 
Neuroimage, 159, 32–45. https://doi.org/10.1016/j.neuroimage.2017.07.021 
Miller, T. J., McGlashan, T. H., Rosen, J. L., Cadenhead, K., Cannon, T., Ventura, J., … Woods, 
S. W. (2003). Prodromal assessment with the structured interview for prodromal 
syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, 
and training to reliability. Schizophrenia Bulletin, 29(4), 703–715. 
https://doi.org/10.1093/oxfordjournals.schbul.a007040 
Miller, T. J., McGlashan, T. H., Rosen, J. L., Somjee, L., Markovich, P. J., Stein, K., & Woods, 
S. W. (2002). Prospective diagnosis of the initial prodrome for schizophrenia based on 
the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater 
reliability and predictive validity. The American Journal of Psychiatry, 159(5), 863–865. 
https://doi.org/10.1176/appi.ajp.159.5.863 
Modinos, G., Simsek, F., Horder, J., Bossong, M., Bonoldi, I., Azis, M., … McGuire, P. (2018). 
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative 
Prodromal Symptoms. The International Journal of Neuropsychopharmacology, 21(2), 
114–119. https://doi.org/10.1093/ijnp/pyx076 
Mullins, P. G., McGonigle, D. J., O’Gorman, R. L., Puts, N. A. J., Vidyasagar, R., Evans, C. J., 
… Edden. (2014). Current practice in the use of MEGA-PRESS spectroscopy for the 
detection of GABA. Neuroimage, 86, 43–52. 
https://doi.org/10.1016/j.neuroimage.2012.12.004 
Murtagh, A., Hurley, A. L., Kinsella, A., Corvin, A., Donohoe, G., Gill, M., … Murphy, K. C. 
(2010). The Letter-Number Sequencing Test and its association with potential to work 
among people with psychotic illness. European Psychiatry, 25(2), 101–104. 
https://doi.org/10.1016/j.eurpsy.2009.06.004 
Overbeek, G., Gawne, T. J., Reid, M. A., Salibi, N., Kraguljac, N. V., White, D. M., & Lahti, A. 
C. (2019). Relationship Between Cortical Excitation and Inhibition and Task-Induced 
Activation and Deactivation: A Combined Magnetic Resonance Spectroscopy and 
Functional Magnetic Resonance Imaging Study at 7T in First-Episode Psychosis. 
Biological Psychiatry : Cognitive Neuroscience and Neuroimaging, 4(2), 121–130. 
https://doi.org/10.1016/j.bpsc.2018.10.002 
 55 
Paoletti, P., Bellone, C., & Zhou, Q. (2013). NMDA receptor subunit diversity: impact on 
receptor properties, synaptic plasticity and disease. Nature Reviews. Neuroscience, 14(6), 
383–400. https://doi.org/10.1038/nrn3504 
Peters, E., Day, S., McKenna, J., & Orbach, G. (1999). Delusional ideation in religious and 
psychotic populations. The British Journal of Clinical Psychology, 38(1), 83–96. 
https://doi.org/10.1348/014466599162683 
Peters, E. R., & Garety, P. A. (1996). The Peters et al. Delusions Inventory (PDI): New norms 
for the 21-item version. Schizophrenia Research, 18(2–3), 118–119. 
https://doi.org/10.1016/0920-9964(96)85403-X 
Peters, E. R., Joseph, S. A., & Garety, P. A. (1995). The measurement of delusional ideation in 
the normal population—-introducing the PDI (PEters et al. delusions inventory). 
Schizophrenia Research, 15(1–2), 19. https://doi.org/10.1016/0920-9964(95)95071-G 
Peters, E. R., Joseph, S. A., & Garety, P. A. (1999). Measurement of delusional ideation in the 
normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophrenia 
Bulletin, 25(3), 553–576. https://doi.org/10.1093/oxfordjournals.schbul.a033401 
Pinheiro, A. P., Schwartze, M., & Kotz, S. A. (2018). Voice-selective prediction alterations in 
nonclinical voice hearers. Scientific Reports, 8(1), 14717. https://doi.org/10.1038/s41598-
018-32614-9 
Piskulic, D., Liu, L., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., McGlashan, T. H., … 
Addington, J. (2016). Social cognition over time in individuals at clinical high risk for 
psychosis: Findings from the NAPLS-2 cohort. Schizophrenia Research, 171(1–3), 176–
181. https://doi.org/10.1016/j.schres.2016.01.017 
Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Javitt, D. C., Lieberman, J. A., Abi-Dargham, 
A., & Girgis, R. R. (2014). Glutamatergic abnormalities in schizophrenia: a review of 
proton MRS findings. Schizophrenia Research, 152(2–3), 325–332. 
https://doi.org/10.1016/j.schres.2013.12.013 
Powers, A R, & Corlett, P. R. (2018). Shamanism and psychosis: Shared mechanisms? 
Behavioral and Brain Sciences, 41, e83. https://doi.org/10.1017/S0140525X1700214X 
Powers, A R, Gancsos, M. G., Finn, E. S., Morgan, P. T., & Corlett, P. R. (2015). Ketamine-
Induced Hallucinations. Psychopathology, 48(6), 376–385. 
https://doi.org/10.1159/000438675 
Powers, A R, Mathys, C., & Corlett, P. R. (2017). Pavlovian conditioning-induced hallucinations 
result from overweighting of perceptual priors. Science, 357(6351), 596–600. 
https://doi.org/10.1126/science.aan3458 
Powers, Addington, J., Perkins, D. O., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., … 
Woods, S. W. (2019). Duration of the psychosis prodrome. Schizophrenia Research. 
https://doi.org/10.1016/j.schres.2019.10.051 
Powers, Albert R, Kelley, M. S., & Corlett, P. R. (2017). Varieties of Voice-Hearing: Psychics 
and the Psychosis Continuum. Schizophrenia Bulletin, 43(1), 84–98. 
https://doi.org/10.1093/schbul/sbw133 
Purdon, S. E., Valiakalayil, A., Hanstock, C. C., Seres, P., & Tibbo, P. (2008). Elevated 3T 
proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-
0X) scores and genetic risk for schizophrenia. Schizophrenia Research, 99(1–3), 218–
224. https://doi.org/10.1016/j.schres.2007.11.028 
Raine, A. (1991). The SPQ: a scale for the assessment of schizotypal personality based on DSM-
III-R criteria. Schizophrenia Bulletin, 17(4), 555–564. 
 56 
https://doi.org/10.1093/schbul/17.4.555 
Ranson, A., Broom, E., Powell, A., Chen, F., Major, G., & Hall, J. (2019). Top-Down 
Suppression of Sensory Cortex in an NMDAR Hypofunction Model of Psychosis. 
Schizophrenia Bulletin, 45(6), 1349–1357. https://doi.org/10.1093/schbul/sby190 
Ratcliff, K., Farhall, J., & Shawyer, F. (2011). Auditory hallucinations: a review of assessment 
tools. Clinical Psychology & Psychotherapy, 18(6), 524–534. 
https://doi.org/10.1002/cpp.729 
Rossi, A., & Daneluzzo, E. (2002). Schizotypal dimensions in normals and schizophrenic 
patients: a comparison with other clinical samples. Schizophrenia Research, 54(1–2), 67–
75. https://doi.org/10.1016/s0920-9964(01)00353-x 
Rowland, L. M., Kontson, K., West, J., Edden, R. A., Zhu, H., Wijtenburg, S. A., … Barker, P. 
B. (2013). In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. 
Schizophrenia Bulletin, 39(5), 1096–1104. https://doi.org/10.1093/schbul/sbs092 
RStudio Team. (2015). RStudio: Integrated Development for R. (1.1.442). Boston, MA: RStudio 
Inc. 
Schlosser, D. A., Jacobson, S., Chen, Q., Sugar, C. A., Niendam, T. A., Li, G., … Cannon, T. D. 
(2012). Recovery from an at-risk state: clinical and functional outcomes of putatively 
prodromal youth who do not develop psychosis. Schizophrenia Bulletin, 38(6), 1225–
1233. https://doi.org/10.1093/schbul/sbr098 
Schwerk, A., Alves, F. D. S., Pouwels, P. J. W., & van Amelsvoort, T. (2014). Metabolic 
alterations associated with schizophrenia: a critical evaluation of proton magnetic 
resonance spectroscopy studies. Journal of Neurochemistry, 128(1), 1–87. 
https://doi.org/10.1111/jnc.12398 
Seidman, L. J., Giuliano, A. J., Meyer, E. C., Addington, J., Cadenhead, K. S., Cannon, T. D., … 
North American Prodrome Longitudinal Study (NAPLS) Group. (2010). 
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to 
family history and conversion to psychosis. Archives of General Psychiatry, 67(6), 578–
588. https://doi.org/10.1001/archgenpsychiatry.2010.66 
Shakeel, M. K., Lu, L., Cannon, T. D., Cadenhead, K. S., Cornblatt, B. A., McGlashan, T. H., … 
Addington, J. (2019). Longitudinal changes in social cognition in individuals at clinical 
high risk for psychosis: An outcome based analysis. Schizophrenia Research, 204, 334–
336. https://doi.org/10.1016/j.schres.2018.08.032 
Shankman, S. A., Funkhouser, C. J., Klein, D. N., Davila, J., Lerner, D., & Hee, D. (2018). 
Reliability and validity of severity dimensions of psychopathology assessed using the 
Structured Clinical Interview for DSM-5 (SCID). International Journal of Methods in 
Psychiatric Research, 27(1). https://doi.org/10.1002/mpr.1590 
Simon, A. E., Borgwardt, S., Riecher-Rössler, A., Velthorst, E., de Haan, L., & Fusar-Poli, P. 
(2013). Moving beyond transition outcomes: meta-analysis of remission rates in 
individuals at high clinical risk for psychosis. Psychiatry Research, 209(3), 266–272. 
https://doi.org/10.1016/j.psychres.2013.03.004 
Simpson, R., Devenyi, G. A., Jezzard, P., Hennessy, T. J., & Near, J. (2017). Advanced 
processing and simulation of MRS data using the FID appliance (FID-A)-An open 
source, MATLAB-based toolkit. Magnetic Resonance in Medicine, 77(1), 23–33. 
https://doi.org/10.1002/mrm.26091 
Sterzer, P., Adams, R. A., Fletcher, P., Frith, C., Lawrie, S. M., Muckli, L., … Corlett, P. R. 
(2018). The predictive coding account of psychosis. Biological Psychiatry, 84(9), 634–
 57 
643. https://doi.org/10.1016/j.biopsych.2018.05.015 
Stone, J. M., Day, F., Tsagaraki, H., Valli, I., McLean, M. A., Lythgoe, D. J., … OASIS. (2009). 
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to 
gray matter volume. Biological Psychiatry, 66(6), 533–539. 
https://doi.org/10.1016/j.biopsych.2009.05.006 
Stone, J. M., Howes, O. D., Egerton, A., Kambeitz, J., Allen, P., Lythgoe, D. J., … McGuire, P. 
(2010). Altered relationship between hippocampal glutamate levels and striatal dopamine 
function in subjects at ultra high risk of psychosis. Biological Psychiatry, 68(7), 599–602. 
https://doi.org/10.1016/j.biopsych.2010.05.034 
Teufel, C., Subramaniam, N., Dobler, V., Perez, J., Finnemann, J., Mehta, P. R., … Fletcher, P. 
C. (2015). Shift toward prior knowledge confers a perceptual advantage in early 
psychosis and psychosis-prone healthy individuals. Proceedings of the National Academy 
of Sciences of the United States of America, 112(43), 13401–13406. 
https://doi.org/10.1073/pnas.1503916112 
Tor, J., Dolz, M., Sintes, A., Muñoz, D., Pardo, M., de la Serna, E., … Baeza, I. (2018). Clinical 
high risk for psychosis in children and adolescents: a systematic review. European Child 
& Adolescent Psychiatry, 27(6), 683–700. https://doi.org/10.1007/s00787-017-1046-3 
Turner, C. E., & Gant, N. (2014). The biochemistry of creatine. In Magnetic Resonance 
Spectroscopy (pp. 91–103). Elsevier. https://doi.org/10.1016/B978-0-12-401688-
0.00007-0 
Uhlhaas, P. J., Gajwani, R., Gross, J., Gumley, A. I., Lawrie, S. M., & Schwannauer, M. (2017). 
The Youth Mental Health Risk and Resilience Study (YouR-Study). BMC Psychiatry, 
17(1), 43. https://doi.org/10.1186/s12888-017-1206-5 
Unterrassner, L., Wyss, T. A., Wotruba, D., Ajdacic-Gross, V., Haker, H., & Rössler, W. (2017). 
Psychotic-Like Experiences at the Healthy End of the Psychosis Continuum. Frontiers in 
Psychology, 8, 775. https://doi.org/10.3389/fpsyg.2017.00775 
Unterrassner, L., Wyss, T. A., Wotruba, D., Haker, H., & Rössler, W. (2017). The Intricate 
Relationship between Psychotic-Like Experiences and Associated Subclinical Symptoms 
in Healthy Individuals. Frontiers in Psychology, 8, 1537. 
https://doi.org/10.3389/fpsyg.2017.01537 
Wang, C., Ulbert, I., Schomer, D. L., Marinkovic, K., & Halgren, E. (2005). Responses of 
human anterior cingulate cortex microdomains to error detection, conflict monitoring, 
stimulus-response mapping, familiarity, and orienting. The Journal of Neuroscience, 
25(3), 604–613. https://doi.org/10.1523/JNEUROSCI.4151-04.2005 
Waters, F. A. ., Badcock, J. C., & Maybery, M. T. (2003). Revision of the factor structure of the 
Launay–Slade Hallucination Scale (LSHS-R). Personality and Individual Differences, 
35(6), 1351–1357. https://doi.org/10.1016/S0191-8869(02)00354-9 
Weschler, D. (Ed.). (2010). WAIS-IV Clinical Use and Interpretation. Elsevier. 
https://doi.org/10.1016/C2009-0-01910-2 
White, T. L., Monnig, M. A., Walsh, E. G., Nitenson, A. Z., Harris, A. D., Cohen, R. A., … 
Fekir, S. (2018). Psychostimulant drug effects on glutamate, Glx, and creatine in the 
anterior cingulate cortex and subjective response in healthy humans. 
Neuropsychopharmacology, 43(7), 1498–1509. https://doi.org/10.1038/s41386-018-
0027-7 
Wilson, M., Reynolds, G., Kauppinen, R. A., Arvanitis, T. N., & Peet, A. C. (2011). A 
constrained least-squares approach to the automated quantitation of in vivo 1H magnetic 
 58 
resonance spectroscopy data. Magnetic Resonance in Medicine, 65(1), 1–12. 
https://doi.org/10.1002/mrm.22579 
Yahya, A., Mädler, B., & Fallone, B. G. (2008). Exploiting the chemical shift displacement 
effect in the detection of glutamate and glutamine (Glx) with PRESS. Journal of 
Magnetic Resonance, 191(1), 120–127. https://doi.org/10.1016/j.jmr.2007.12.007 
Yaralian, P. S., Raine, A., Lencz, T., Hooley, J. M., Bihrle, S. E., Mills, S., & Ventura, J. (2000). 
Elevated levels of cognitive-perceptual deficits in individuals with a family history of 
schizophrenia spectrum disorders. Schizophrenia Research, 46(1), 57–63. 
https://doi.org/10.1016/s0920-9964(99)00239-x 
Yeung, N., & Nieuwenhuis, S. (2009). Dissociating response conflict and error likelihood in 
anterior cingulate cortex. The Journal of Neuroscience, 29(46), 14506–14510. 
https://doi.org/10.1523/JNEUROSCI.3615-09.2009 
Yoo, S. Y., Yeon, S., Choi, C.-H., Kang, D.-H., Lee, J.-M., Shin, N. Y., … Kwon, J. S. (2009). 
Proton magnetic resonance spectroscopy in subjects with high genetic risk of 
schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and 
thalamus. Schizophrenia Research, 111(1–3), 86–93. 
https://doi.org/10.1016/j.schres.2009.03.036 
Zammit, S., Kounali, D., Cannon, M., David, A. S., Gunnell, D., Heron, J., … Lewis, G. (2013). 
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic 
experiences at age 12 in a longitudinal population-based cohort study. The American 
Journal of Psychiatry, 170(7), 742–750. https://doi.org/10.1176/appi.ajp.2013.12060768 
Zmigrod, L., Garrison, J. R., Carr, J., & Simons, J. S. (2016). The neural mechanisms of 
hallucinations: A quantitative meta-analysis of neuroimaging studies. Neuroscience and 
Biobehavioral Reviews, 69, 113–123. https://doi.org/10.1016/j.neubiorev.2016.05.037 
Zoghbi, A. W., Bernanke, J. A., Gleichman, J., Masucci, M. D., Corcoran, C. M., Califano, A., 
… Girgis, R. R. (2019). Schizotypal personality disorder in individuals with the 
Attenuated Psychosis Syndrome: Frequent co-occurrence without an increased risk for 
conversion to threshold psychosis. Journal of Psychiatric Research, 114, 88–92. 
https://doi.org/10.1016/j.jpsychires.2019.04.018 
 
